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CHARACTERIZATION OF THE AI-2-DEPENDENT QUORUM SENSING 
PATHWAY IN AGGREGATIBACTER ACTINOMYCETEMCOMITANS. 
By 
Elizabeth A. Novak 
December 16, 2011 
Quorum sensing in the oral pathogen Aggregatibacter actinomycetemcomitans is 
dependent upon the soluble signaling molecule AI-2, but it is not known how the initial 
detection of AI-2 is coupled to the downstream regulation of gene expression that confers 
complex phenotypes such as biofilm formation and iron acquisition. Here we show that 
expression of a two-component system encoded by qseBC is induced by AI-2 in A. 
actinomycetemcomitans and that induction of qseBC requires the AI-2 receptors, LsrB 
and/or RbsB. Inactivation of the sensor kinase gene qseC resulted in a significant 
reduction of in vitro biofilm growth and in vivo virulence using a murine model of 
periodontitis. We also show that qseBC regulates the expression of several operons 
encoding iron acquisition pathways, consistent with previous studies showing that AI-2 
Vll 
regulates iron uptake in A. actinomycetemcomitans. However, some AI-2 regulated iron 
uptake operons were not controlled by QseBC, suggesting that only a subset of iron 
acquisition systems are co-regulated by AI-2 and QseBC. 
Interestingly, the toxin-antitoxin system mqsRA is involved in AI-2 and QseBC-
dependent regulation of biofilm growth of some strains of Escherichia coli. The genome 
sequence of A. actinomycetemcomitans was searched and open reading frames Aa00672 
and Aa00673 were shown to exhibit sequence similarity to MqsRA and MazEF, two 
toxin-antitoxin systems encoding mRNA interferases. Aa00673 was shown by RT-PCR 
to be co-expressed with Aa00672 and the expression of Aa00672-Aa00673 was 
decreased in A. actinomycetemcomitans strains lacking functional AI-2-receptors or 
QseC, suggesting that Aa00672-Aa00673 functions downstream from the AI-2 receptors 
and QseBC in the AI-2 response circuit of A. actinomycetemcomitans. We also 
demonstrate that Aa00673 encodes a toxin, which causes reversible growth inhibition and 
may function as an RNase~ whereas Aa00672 encodes its cognate antitoxin, negating the 
effects of the toxin. Thus, our results suggest that the QseBC two-component system is 
part of the AI-2 regulon and in concert with Aa00673, a putative paralog of MqsR, link 
the detection of AI-2 to the regulation of genes controlling biofilm formation, iron 
acquisition, and in vivo virulence of A. actinomycetemcomitans. 
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CHAPTER ONE: INTRODUCTION 
During the early 1900s, shortly after the prevalent acceptance of both bacteriology 
and the germ theory, increased awareness of public hygiene resulted in the expectation 
that most, if not all, diseases would prove to be of infectious origin (125, 186). One 
popular idea that championed such a belief was the theory of focal infection. This theory 
proposed that a myriad of systemic diseases were the result of the dissemination of 
microorganisms or toxic products from a focus of infection (186). The popularity of this 
theory resulted in the therapeutic extraction of teeth (125). While the theory of focal 
infection was a product of the intellectual environment of its time, inconsistencies in 
studies supporting the theory including the inability of healthy tooth extraction to provide 
relief of illness symptoms, led to its discreditation (125). In recent years, however, the 
controversial focal infection theory has received a resurgence of support as the potential 
impact of periodontal diseases is becoming more apparent in systemic health. Current 
research has focused on the ability of the oral cavity to serve as a reservoir for 
dissemination of pathogenic and commensal organisms to distant body sites, especially in 
immunocompromised hosts. The correlation between periodontal disease and systemic 
diseases such as diabetes, cardiovascular disease (104), respiratory disease (21, 90, 149, 
187, 254), and adverse pregnancy outcomes (156, 157) has been and continues to be 
investigated. A number of epidemiological studies have suggested that oral infection, 
especially periodontitis, may be a risk factor for many different systemic diseases. On 
May 25, 2000, the U.S. Surgeon General issued a report on Oral Health, emphasizing that 
oral health is more than healthy teeth-it is integral to general health and the two should 
not be considered separate entities (225). 
Periodontal Disease 
Periodontal disease is a progressive inflammatory disease of the periodontium 
(tissues surrounding the teeth). Depending on the severity of the disease, these are 
classified as either gingivitis or periodontitis (Figure 1). Gingivitis, the initial stage of 
periodontal disease, is an inflammation of the gingival tissue characterized by swelling, 
redness, and bleeding upon probing of the gingiva (8). Although gingivitis is reversible 
following proper oral hygiene, if left untreated, it can progress into the more severe, 
chronic inflammatory condition, periodontitis. Periodontitis is characterized by persistent, 
uncontrolled inflammation that ultimately causes destruction of the supporting soft 
tissues surrounding the teeth, loss of gingival fibers and periodontal ligaments, and 
resorption of the alveolar bone. This can lead to eventual tooth loss and possibly even 
edentulism (loss of most or all teeth) (10, 169). While treatment and proper oral hygiene 
can stop the progression of periodontitis, the damage caused cannot be reversed. 
Periodontal disease is the most prevalent of bone diseases in humans and has long 
been implicated as a risk factor in impairment of oral functions and tooth loss, where 10-
15% of adults have periodontal disease severe enough to result in tooth loss. While 
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periodontal disease is prevalent worldwide, it is also serious health problem in the United 
States (25, 60, 169). Brown et al estimate that about 21.8% of adults (22.6 million) 
exhibit signs of mild periodontitis, 9.5% (9.9 million) display signs of moderate 
periodontitis, and about 3.1 % (about 3.2 million) exhibit signs of advanced periodontitis 
(25). The total amount expended for periodontal preventive procedures as well as the 
treatment of periodontal diseases in the U.S. was $14.3 billion in 1999 (25). 
Undoubtedly, innovative methods for the prevention and treatment of periodontal disease 
would have a major impact on healthcare costs. It is known that periodontal disease can 
be complicated by certain systemic diseases, and more recently, studies suggest that the 
reverse may also be true (39, 76, 77, 83, 149, 157, 158, 161, 247, 254). Research 
proposes that periodontal disease has important systemic implications, and can influence 
other diseases such as cardiovascular disease (76, 77, 104, 127), pulmonary disease (21, 
90, 149, 187, 247, 254), diabetes (65, 83, 161, 222), and adverse pregnancy outcomes 
(37, 157, 158). Thus, a better understanding of factors that contribute to periodontal 
disease can be used to develop measures to improve not only oral health, but also overall 
health of individuals. 
The onset and progression of periodontal disease is associated with several risk 
factors, including gender, age, socio-economic status, nutrition, stress, genetic makeup, 
and tobacco smoke. Albander et al (4) illustrated an increased prevalence of periodontal 
disease among males (10% greater) as compared with females, confirming estimates 
produced by the third National Health and Nutrition Examination Survey (NHANES III), 
which suggested that there was a gender-specific severity of the disease with males 
having a higher likelihood of developing disease. It was also shown that adults beyond 
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the age of 30 years had increased levels of periodontitis; whereas after 70 years of age, 
the progression of severe periodontitis decreased (4). However, individual socio-
economic status has an even more significant effect on the progression of periodontal 
disease. Individuals with higher-income and better insurance providers are more likely to 
receive necessary treatment compared to uninsured or lower-income patients (4). 
Smoking is considered one of the most important risk factors associated with 
periodontal disease (182). As such, it has been theorized that increased tobacco usage in 
populations is directly related to increased numbers of periodontal cases (84, 169). A 
dose-dependent correlation has been demonstrated between an individual's smoking 
status and deteriorating periodontal health (18). Smokers are extremely susceptible to 
periodontitis, and, compared to non-smokers, the disease is often more severe with 
increased alveolar bone resorption (66), attachment loss, percentage of oral sites with 
significant attachment loss (67), tooth mobility, and tooth loss (138). Additionally, 
patients who smoke are more often refractory to treatment than non-smokers (160). 
Despite conflicting data that tobacco smoke may not influence the sub-gingival 
micro flora (22, 36, 170, 213), recent data strongly indicates that tobacco-induced 
susceptibility to periodontitis is correlated with populational shifts in the microbial 
composition of the oral biofilm (28, 49, 61, 69, 95, 198, 226, 229, 251). For example, 
Umeda et al showed that there is an increased risk of Treponema denticola inhabiting the 
oral cavity of smokers (226); while Zambon et al reported a higher prevalence of 
Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Porphyromonas 
gingivalis in smokers (251). Recent studies also indicate that in addition to changing the 
composition of the flora, smoking can lead to changes in the activities of residential 
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bacteria. Bagaitkar et al showed that P. gingivalis exhibited increased fimbriae 
expression when grown in medium exposed to tobacco smoke (11). 
While all of these factors playa role in the progression and severity of the disease, 
there is clear evidence that the inflammatory response in the periodontum is initially 
initiated against the resident microbial biofilm within the subgingival pocket. The oral 
biofilm consists of several hundred bacterial species, but disease is often associated with 
a succession in the predominant bacterial species in dental plaque from Gram-positive to 
Gram-negative. Subgingival colonization by periodontal pathogens is aided by the 
regulated expression of several immune-evading virulence factors. Bacterial behaviors 
and the resulting immune response to these pathogens combine to promote inflammatory 
tissue destruction in periodontitis. The production of various pro inflammatory cytokines 
(i.e. IL-IB, IL-6, TNFa, IL-8, and RANKL) in response to specific Gram-negative 
bacteria within the oral cavity leads to the activation of osteoclasts (105). Activation of 
the bone-resorbing osteoclasts (as opposed to bone-forming osteoblasts) eventually 
results in bone resorption and alveolar bone loss-clinical symptoms of periodontitis (73, 
136, 150, 167). 
Microbial Induction of Periodontal Disease 
Dental plaque is the single most important risk factor associated with the onset 
and progression of periodontal disease. A hallmark of inflammatory periodontal disease 
is the increased subgingival colonization by several Gram-negative species, including A. 
actinomycetemcomitans, Prevotella intermedia, Campylobacter rectus, and a group of 
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Figure 1. Anatomy of the periodontium (as reviewed by Baker, P.J. (12)). 
A) In health, gingival fibers connect the gingival soft tissue to the root of the 
tooth, and the alveolar bone and cementum are connected by periodontal ligament 
fibers. B) In periodontal disease, subgingival infection by Gram-negative bacteria 
results in soft tissue damage, producing attachment loss and deepening the sulcus 
into the periodontal pocket. Alveolar bone resorption moves the bone surface 
away from the tooth root (vertical bone loss) and reduces the height of the alveolar 
bone crest (horizontal bone loss). Copyright permission to reproduce figure 
granted by Elsevier and (12). 
P. gingivalis) (129). The oral biofilm is one of the most accessible of natural microbial 
ecosystems-about 50% of the microbes in the oral cavity have been cultivated compared 
to only about 1 % of the population of other ecosystems. It is also complex and potentially 
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the most pathogenic biofilm present in humans, but its existence is not necessarily 
detrimental to oral health (194). 
A biofilm is a structured community of microorganisms that are adhered to a 
surface and enclosed in a self-generated matrix that can include proteins, nucleic acids, 
and carbohydrates. In most cases, biofilms are more resistant to antimicrobial reagents 
than planktonic cells, and this increased resistance may be mediated by populations of 
slow-growing cells or persistors, up-regulation of antimicrobial systems (e.g., efflux 
transporters) in biofilm cells, and semi-permeable intercellular matrices (212). Moreover, 
the ability of bacteria to adhere tightly to underlying substrata impedes the efficient 
removal of biofilms by physical or chemical means. In the oral cavity, biofilms form on 
the surfaces of both hard and soft tissues, and the development of the biofilm depends on 
interactions between both bacterial cell-surface adhesions and host receptors and 
bacteria-bacteria interactions. Without the ability to adhere to surfaces in the oral cavity, 
bacteria are swallowed with the saliva and enter the digestive tract, where they may not 
surVIve. 
In children, the oral biofilm begins forming on teeth within hours after their 
eruption from the gingiva while in adults it begins re-forming within minutes after 
cleaning. Both processes begin with the deposition and formation of the host-derived 
salivary pellicle. Initial colonizers of the enamel surface-primarily streptococci and 
actinomyces-recognize and bind to receptors of the salivary pellicle that form on the 
tooth surface (Figure 2) (40, 42, 86, 155). The initial colonizers also co adhere and 
coaggregate with each other, successfully forming a bacterial substrate on the enamel of 
the tooth for other colonizers. Other early colonizers then adhere to and co aggregate with 
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the already-attached cells, increasing interactions and species diversity of the biofilm. 
Early colonizers include genera such as Neisseria, Prevotella, Eikenella, Rothia, 
Porphyromonas, and Veillonella (112). The next stage of colonization comprises the 
middle colonizers-species not commonly found in initial or early plaque. Middle 
colonizers must be able to compete with early and initial colonizers, and therefore 
necessitate different manners of interactions than seen in the early or initial colonizers. 
For example, Fusobacterium nucleatum is capable of binding to many of the initial and 
early colonizers (6, 109); whereas the early colonizers coaggregate with a specific set of 
other early colonizers and generally not with any late colonizers (108, 110,237). Since F. 
nucleatum and other middle colonizers are not often associated with disease (as they 
colonize the oral cavity before signs of disease are apparent), they are often thought of as 
the organisms that bridge health and disease (111). The last stage of colonization involves 
late colonizers, whose presence is often associated with periodontal disease progression. 
The red complex is microorganisms that are most intimately associated with adult 
periodontal disease and include P. gingivalis, T. denticola, and T. forsythia (206). A. 
actinomycetemcomitans, another late colonizer, is associated with an aggressive form of 
periodontitis primarily found in juveniles, but which may also occur in older individuals 
(72, 203). All four of these species are known to co aggregate with F. nucleatum, which 
is possibly why they appear so late in the oral biofilm. 
The oral biofilm consists of several hundred bacterial species living in 
consortium, establishing a physiologically-compatible microenvironment which allows 
for metabolic interactions. Metabolic interactions are beneficial interactions that are 
facilitated by the excretion of a metabolite by one organism that can be utilized as a 
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nutrient by a different orgamsm; or through the extracellular enzymatic activity of 
another bacterium which results in the breakdown of a substrate and subsequently 
creating available nutrients for other organisms. For example, streptococci produce lactic 
acid as a metabolic waste product, but lactic acid is a major energy source for A. 
actinomycetemcomitans. Brown and Whiteley demonstrated that A. 
actinomycetemcomitans did not grow in medium containing sucrose as the sole carbon 
source, but it was capable of growing in the presence of Streptococcus gordonii because 
S. gordonii converted sucrose to lactate (26). Similarly, interaction of P. gingivalis with 





Figure 2. Stages in the formation of the oral biofilm (86). Immediately 
after cleaning, the salivary pellicle coats the tooth. Colonization of the tooth 
surface is initated by bacteria adhering to the salivary pellicle. Diversity and 
biomass of the biofilm builds as other bacterial species bind to the existing 
bacterial layer. Adherent bacteria produce a matrix of complex carbohydrates, 
and extracellular nucleic acids that help bind the biofilm together and protect 
the encased cells. Periodontal disease arises from a shift in the microflora and 
accumulation of pathogenic bacteria. Copyright permission to reproduce 
figure granted by Wiley and (86). 
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F. nucleatum facilitates the growth of P. gingivalis under aerobic conditions because of 
the production of carbon dioxide by F. nucleatum (41). Grenier et al also showed that the 
production of fatty acids by P. gingivalis promotes the growth and biofilm formation of 
the oral spirochete T. denticola (63, 64). Additionally, in the murine subcutaneous lesion 
model, simultaneous injection of both P. gingivalis and F. nucleatum resulted in larger 
lesions and higher morbidity than did injections of either single species alone (48). Thus, 
these microbial cross-feedings eventually allow for the temporal formation of microbial 
biofilms in the oral cavity and may also contribute to the increased virulence potential of 
periodontal pathogens, leading to the development of disease. 
Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans (formerly Actinobacillus actinomycetemcomitans) is a 
small, fastidious, CO2-requiring coccobacillus (94). It is a facultative anaerobic Gram-
negative bacterium that belongs to the family Pasteurellaceae (94). A. 
actinomycetemcomitans was initially isolated from actinomycotic oral lesions along with 
Actinomyces israelii, leading to the derivation of its species name (80). However, 
although A. actinomycetemcomitans was first isolated in 1912 (106), it was never 
recognized as a member of the oral microbota until 1975 (99). A. actinomycetemcomitans 
has been associated with several systemic infections (e.g. endocarditis (7, 230), brain 
abscesses (135, 230), bacterimia, infective arthritis (148), and urinary tract infections 
(223)) and is also strongly associated with localized aggressive periodontitis, an 
extremely destructive form of periodontal disease that is most common in adolescents 
(203). As such, most studies of A. actinomycetemcomitans have focused on its role in this 
10 
disease. If left untreated, localized aggressive periodontitis results in rapid destruction of 
the supporting structures of the teeth, and eventually leads to loss of alveolar bone and, 
subsequently, tooth loss-specifically the incisors and first molars (248, 249). Significant 
geographic differences in the burden of localized aggressive periodontitis have been 
reported, suggesting that geographical location, socio-economic status, and race are 
important factors in the prevalence of the disease (183, 204). Nevertheless, A. 
actinomycetemcomitans is a prevalent pathogen in the population and is often found 
inhabiting the subgingival plaque (204). 
A. actinomycetemcomitans, like other pathogens, utilizes a myriad of virulence 
factors to cause disease. There is strong evidence that leukotoxin expression affects 
disease progression (23,81,211). Leukotoxin (LtxA) is a 116-kDa protein that belongs to 
the repeats-in-toxin (RTX) family of pore-forming toxins exemplified by other Gram-
negative bacteria, such as Escherichia coli (68, 91, 114, 117). Studies have demonstrated 
that onset of disease develops at an earlier age in individuals harboring a clonal variant of 
A. actinomycetemcomitans (strain JP2), which expresses high levels of leukotoxin as a 
result of a deletion in the promoter region upstream from the toxin operon (23, 81, 211). 
Additionally, disease is more likely to occur in individuals infected with this clone than 
those infected with other strains of the organism which express only minimal levels of 
leukotoxin (71). Studies have shown that the target of LtxA is quite specific, which is 
unusual among RTX toxins, killing only polymorphonuclear leukocytes, monocytes and 
T-cells in humans, apes, and Old World monkeys (220, 221). 
A. actinomycetemcomitans also expresses several other potential virulence factors 
(53), including catalase (45, 147), IgA protease (233), OmpA-like protein (115, 235), 
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capsular polysaccharide biosynthetic enzymes (246), cytolethal-distending toxin (137, 
172, 197), and fimbriae production. Previous studies have demonstrated the ability of A. 
actinomycetemcomitans to bind and invade epithelial (142, 143) and endothelial cells 
(192), which may be an important mechanism for evading the host immune system and 
disseminating beyond the initial site of infection (53). Furthermore, fresh clinical isolates 
Figure 3. Characteristics of clinical isolates of A. actinomycetemcomitans 
(52). A) When A. actinomycetemcomitans is initially isolated from the oral 
cavity and cultured on solid medium, it grows as a 'rough' colony with a 
characteristic star-like structure in the center. B) As the bacterium is passaged 
in liquid broth, it loses its ability to express fimbriae due to a spontaneous 
mutation in the f/p promoter region, and the broth becomes turbid with the 
growth of isogenic non-adherent variants. When plated on solid medium, 
these variants form large, smooth colonies (52). Copyright permission to 
reproduce figure granted by Society for General Microbiology and (52) . 
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of A. actinomycetemcomitans express fimbriae (Figure 3), which allow them to form 
tenacious biofilms on a variety of solid surfaces, such as hydroxyapatite, glass, and 
plastic (52, 93, 181, 202). In broth cultures, this bacterium adheres tightly to the culture 
vessel, forming dense microcolonies (51, 52, 85, 92, 181, 201, 203). The broth remains 
clear as the biofilm grows; however, older biofilms ultimately have turbid broth from the 
growth of isogenic non-adherent variants (51, 52, 85, 92, 181,201,203). While fimbriae 
expression may be important in biofilm pathogenesis in vivo, it is not the sole 
determinant in biofilm formation, as isogenic smooth strains are capable of forming 
biofilms (196). Even so, these fimbriae are thought to enable A. actinomycetemcomitans 
to colonize the tooth surface, persist in the oral cavity, and initiate infection in the 
presence of salivary flow. 
Quorum Sensing 
The most common forms of oral diseases, dental caries and periodontal disease, 
have been linked with the formation and maturation of dental plaque. Furthermore, the 
populations of pathogens relative to residential microbes are increased at diseased sites, 
suggesting that major shifts in microbial populations within the oral biofilm may 
contribute to the disease process (37). Interestingly, the oral cavity experiences constant, 
continual environmental fluxes, such as pH, temperature, osmolarity, and changes in the 
nutrient supply, which may contribute, in part, to these microbial population shifts. Oral 
bacteria are able to detect these fluctuations in the environment and appropriately 
respond, allowing them to successfully coexist and adapt in dental plaque. However, it is 
still unknown how host and/or microbial signals are instrumental in orchestrating these 
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population shifts, or even how bacteria are able to detect changes in their surrounding 
environment and properly respond. 
Both intra- and interspecies communication occurs between bacteria, which 
enables the bacteria to coordinate their behavior and function, and regulate their gene 
expression as a community. One mechanism of communication, termed quorum sensing 
(Figure 4), is a cell-density dependent response (116, 140, 190, 253). In Gram-negative 
bacteria, quorum sensing is mediated by the production, release, and detection of soluble 
signal molecules called auto inducers , of which there are a multitude of structures 
including acylated homo serine lactones (AHL) (74, 162, 166), quinolone derivatives, and 
furan derivatives (e.g. AI-2) (140, 190, 236, 240). As a population of bacteria expands, 
the external concentration of autoinducer increases until the rate of secretion is balanced 
by influx back into the bacterial cell. The population of bacteria is able to detect the 
auto inducer once it reaches a certain threshold, at which point a signal transduction 
cascade is initiated, resulting in changes in gene expression, and accordingly behavior, in 
the community of bacteria. Quorum sensing controls cell-density dependent phenotypes 
such as virulence-factor expression, biofilm formation, and iron acquisition (14, 74, 236, 
238). In this sense, quorum sensing allows single-cell organisms to react coordinately as 
multi-cellular organisms. 
Autoinducer-2 Quorum Sensing Pathway 
The contribution of quorum sensing pathways to the development of biofilms was 
initially characterized in the non-oral organism Pseudomonas aeruginosa (38, 163). 
Indeed, cell-to-cell communication, mediated by the diffusible AHL signals, was shown 
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to influence the expresslOn of virulence factors in P. aeruginosa (163). Studies that 
measured biofilm formation on enamel chips implanted in the oral cavity were the first to 
shed light onto the contribution of soluble autoinducer-like molecules to dental biofilm 
development (126). However, surveys of oral bacteria utilizing a variety of reporter 
systems designed to detect AHL autoinducers failed to demonstrate the presence of 
quorum-sensing signals (58, 237), and queries of the genomes of several oral bacteria 
failed to identify genes encoding proteins that exhibit similarity to known AHL, 
suggesting that these AHL-based systems may not be prevalent in oral bacteria. 
Figure 4. Quorum sensing leads to bioluminescence in Vibrio spp. 
When Vibrio grows, it produces and releases to the environment soluble-
signaling molecules called autoinducers. As the population increases, the 
autoinducers accumulate until they reach a certain threshold, which results 
in the activation of different sets of genes allowing them to survive 
environmental changes. Thus, bioluminescence occurs once the 
population of Vibrio reaches levels allowing for the activation of the lux 
operon. 
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Studies of Vibrio harveyi identified a second type of quorum sensing autoinducer, 
autoinducer-2 (AI-2) (16), and the /uxS gene was subsequently shown to be the synthase 
for this autoinducer (216). Based upon these findings, oral bacteria were then re-
examined, using a reporter specific for AI-2, for the presence of AI-2-dependent quorum 
sensing systems. P. gingivalis and P. intermedia were shown to produce a soluble 
molecule that stimulated the AI-2 quorum sensing circuit of the V. harveyi reporter strain 
and induce bioluminescence (58). Subsequently, the genomes of P. gingivalis (27, 34), A. 
actinomycetemcomitans (54), and several other species of oral streptococci (19, 139, 141, 
234) were shown to have genes encoding polypeptides related to the LuxS protein of V. 
harveyi. The conditioned culture medium from these organisms was also shown to 
contain an AI-2-like compound that was capable of stimulating the AI-2 quorum sensing 
circuit of V. harveyi. Thus, while the oral bacteria that have been examined to date do not 
appear to possess AHL-dependent quorum sensing pathways, many do produce an AI-2-
like signaling molecule, suggesting that these organisms possess an AI-2 quorum sensing 
pathway. 
Autoinducer-2 requires the luxS gene for its production (Figure 5). LuxS is an 
enzyme that participates in the Activated Methyl Cycle, which functions in the turnover 
of S-adenosyl-L-homocysteine (SAH) and generation of S-adenosyl-L-methionine 
(SAM). LuxS cleaves S-ribosyl-L-homocysteine (SRH) to form L-homocysteine and 4,5-
dihydroxy-2,3-pentanedione (DPD). Homocysteine is then converted to methionine by 
the metH gene, and ultimately, to S-adenosylmethionine by the metK gene. DPD is 
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Figure 5. Relationship between AI-2 production and the Activated Methyl 
Cycle in bacteria (176). The Activated Methyl Cycle functions in the generation 
of S-adenosyl-L-methionine-the major methyl donor in the cell-and in the 
recycling of methionine by detoxification of S-adenosyl-L-homocysteine. In this 
cycle, LuxS is responsible for recovering the homocysteine moiety from S-ribosyl-
homocysteine, and as a result, produces 4,5-dihydroxy-2,3-pentadioine (DPD) as a 
by-product. DPD, the precursor to AI-2, undergoes additional reactions to form 
two distant, biologically-active forms of AI-2. The Vibrionales recognize (2S,4S)-
2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate), which is 
produced in the presence of boric acid (lower pathway). Other bacteria (e.g., S. 
typhimurium) recognize DPD (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF) as AI-2 signal (upper pathway). Copyright 
permission to reproduce figure granted by BMC Microbiology and (176). 
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reactive in aqueous solution and undergoes a spontaneous intramolecular cyc1ization and 
hydration to yield, in chemical equilibrium, the two known forms of AI-2: (2S,4S)-2-
methyl-2,3,3,4-tetrahydroxytetrahydrofuran (S-THMF) and (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF) (144). S- THMF is a cis-diol and is able to react 
with borate ions to form the active quorum-sensing signal, S-THMF-borate, which is 
detected by LuxP, the periplasmic AI-2 receptor of Vibrio spp (29). The other 
stereoisomer, R-THMF, is unable to complex borate, but this form is bound by the 
periplasmic receptor LsrB in Salmonella enterica serovar Typhimurium (145). 
The luxS gene is widely distributed in the Firmicutes and Proteobacteria (122), 
and as such, many Gram-positive and Gram-negative bacterial species express the protein 
LuxS and also secrete and respond to a signal that is capable of stimulating 
bioluminescence in Vibrio. The widespread distribution of luxS has led to the hypothesis 
that AI-2 may be a quorum sensing signal capable of facilitating interspecies 
communication (144, 189). In addition, individual organisms appear capable of adapting 
LuxS signaling for their own needs, as AI-2 has been shown to mediate the expression of 
a variety of cellular processes in different organisms. For example, AI-2 regulates type III 
secretion in enteropathogenic and enterohemorrhagic E. coli (207), protease and 
hemolysin production in Vibrio vulnificus and Streptococcus pyogenes (100, 130), 
biofilm formation in Vibrio cholera, Helicobacter pylori, Streptococcus mutans, and A. 
actinomycetemcomitans (19, 35, 70, 139, 141, 196,245), motility in E. coli and H. pylori 
(128,208), and iron uptake in P. gingivalis and A. actinomycetemcomitans (54, 55, 87). 
The cellular processes regulated by AI-2 in Vibrio spp. are induced by a 
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Figure 6. The AI-2 quorum sensing pathway of V. harveyi integrates with two 
other quorum sensing circuits (224). Under conditions of low cell density when 
AI-2 concentrations are insignificant, LuxO is phosphorylated, and, in conjuction 
with (}"54, activates expression of the Qrr, which interacts with LuxR, repressing 
the genes encoding luciferase. At high cell density when AI-2 concentrations are 
detectable, AI-2 induces the sensor kinase to convert to a phosphatase, resulting 
in the dephosphorylation and inactivation of LuxO. This causes the production of 
Qrr to cease, the mRNA of LuxR to stabilize, and light to be generated. Copyright 
permission to reproduce figure granted by CSH Press and (224). 
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AI-2 is initially detected and bound by LuxP, a periplasmic AI-2 receptor (29). LuxP then 
associates with the membrane-bound autophosphorylating histidine sensor kinase protein, 
LuxQ, which initiates a phosphate-transfer cascade (152). LuxQ transfers a phosphoryl 
group to Lux U, a histidine-containing phosphotranfer protein, which in turn transfers a 
phosphate to the (j54-dependent response regulator LuxO. LuxO mediates the expression 
of several quorum-regulatory RNAs (Qrr) that are bound by Hfq an RNA chaperone. 
LuxO, in concert with Hfq, coordinate the regulation of the master regulator of the lux 
operon, LuxR (120, 121). Under conditions of low cell density, when AI-2 concentrations 
are negligible, the LuxQ sensor phosphorylates LuxO. Phosphorylated LuxO, along with 
(j54, activate expression of Qrr, which destabilizes the mRNA of LuxR, and the genes 
encoding luciferase are not expressed. In contrast, under conditions of high cell density, 
when AI-2 concentrations are high, LuxQ functions as a phosphatase, which results in the 
dephosphorylation of LuxO (57). This inactivates LuxO, which causes the production of 
Qrr to cease, preventing degradation of LuxR mrRNA. LuxR directly activates the lux 
operon (57, 146) and also controls, either directly or indirectly, other known quorum-
sensing target genes (199, 217). 
AI -2-Dependent Quorum Sensing in A. actinomycetemcomitans 
A. actinomycetemcomitans was one of the first oral organisms to be examined for 
AI-2-dependent quorum sensing systems. Fong et al identified the luxS gene in A. 
actinomycetemcomitans and demonstrated that an AI-2-like signal in the culture media 
induced bioluminescence in the V. harveyi reporter strain (55). The activity of AI-2 in A. 
actinomycetemcomitans was shown to be maximal during the exponential growth phase 
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and decreased during late-exponential and stationary phase, implying that AI-2 was either 
degraded or removed from the culture fluid (54). Inactivation of the luxS gene 
demonstrated that the expression of several virulence factors was influenced by luxS. 
Fong et al showed that expression of ltxCABD (encoding the RTX leukotoxin) and 
afuABC (encoding a ferric ion transporter) is decreased in a LuxS-deficient organism 
(55). This suggests that AI-2 may positively regulate leukotoxin expression and iron 
acquisition (55). While it may be possible that these effects are due to metabolic 
disruption arising from the alteration of the Activated Methyl Cycle, two factors suggest 
that the effects were due to the absence of a soluble signaling molecule and not a more 
general metabolic defect. First, exposing A. actinomycetemcomitans to either conditioned 
medium obtained from a late-exponential culture of E. coli AIS (a luxS-deficient 
recombinant strain of E. coli transformed with a plasmid-borne copy of A. 
actinomycetemcomitans luxS) or conditioned medium from a late-exponential phase of A. 
actinomycetemcomitans culture led to a two- to threefold increase in ltxCABD expression 
(55). Furthermore, a luxS- mutation in P. gingivalis, another periodontal pathogen, was 
complemented by conditioned culture medium from A. actinomycetemcomitans (54). 
These results illustrate that the AI-2 signal is capable of complementing the luxS 
mutation alone and is consistent with the hypothesis that AI-2 functions as a multi-
species quorum sensing signal. 
Additional studies found other A. actinomycetemcomitans phenotypes that were 
dependent on AI-2 (55, 56, 195, 196). Following the initial observation that expression of 
a ferric-uptake transporter was altered after inactivation of luxS, Fong et al investigated 
the expression profile of other iron uptake systems. Expression of several genes encoding 
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proteins involved in iron acquisition and storage was significantly altered in a luxS-
mutant. For example, genes encoding putative receptors for heme, transferrin, and 
hemoglobin were downregulated two- to threefold in the iuxS- mutant. Moreover, the 
expression of jtnAB, which encodes an intracellular iron storage protein ferritin, was 
reduced 50-fold in the mutant organism. The expression of ajuABC, encoding a 
peri plasmic ferric ion transporter, was reduced approximately eightfold, consistent with 
earlier observations. Interestingly, inactivation of iuxS resulted in the increased 
transcription of a ferric citrate transport operon and another operon encoding a putative 
periplasmic enterobacterin receptor and ABC transporter (3- and lO-fold, respectively) 
(55). This type of regulation suggests that AI-2 may function in the adaption of A. 
actinomycetemcomitans from a planktonic lifestyle to a biofilm environment by 
facilitating a switch from the uptake of iron via chelators (e.g. enterobactin-like 
siderophores) to the acquisition of iron from host proteins, such as transferrin and 
hemophores. 
Fong et ai also examined the growth of the parent and iuxS-deficient strains under 
iron limitation. The growth rates of both wild-type and iuxS- mutant strains were 
indistinguishable when cells were grown in iron-replete medium. In addition, wildtype A. 
actinomycetemcomitans also had normal growth in the presence of the ferric iron chelator 
ethylenediamine-N,N' -bis(2-hydroxypenylacetic acid) (EDDHA), suggesting that the 
organism is quite effective in competing with the chelator for iron in the culture medium. 
On the contrary, the iuxS- mutant failed to divide when grown in medium containing 
EDDHA. However, complementation of the mutant with a plasmid-borne copy of iuxS 
restored growth to wild-type levels under iron limitation. Moreover, the inhibited growth 
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of the lu~X mutant under iron limitation was reversed when the bacterial cells were 
inoculated back into iron-replete medium (55). 
Shao et al performed subsequent studies which examined the biofilm growth of A. 
actinomycetemcomitans in an open flow chamber and demonstrated that the growth and 
formation of the luxS- mutant on saliva-coated covers lips were defective, exhibiting lower 
total biomass and lower biofilm depth relative to wild-type A. actinomycetemcomitans. 
Restoration of wild-type biofilm growth was achieved by either transforming the mutant 
strain with a functional copy of the luxS gene or by the addition of partially purified AI-2 
to the growth medium (196). Furthermore, transformation of the luxS- mutant with a gene 
encoding SAH hydrolase, which in the absence of luxS restores the activity of the 
Activated Methyl Cycle, did not fully complement the luxS- mutation unless AI-2 was 
also added in trans (196). Collectively, these results imply that iron acquisition and 
biofilm formation of A. actinomycetemcomitans are influenced by AI-2 signaling. Indeed, 
iron uptake and biofilm formation are intimately associated processes in A. 
actinomycetemcomitans as both are essential for colonization and persistence in the oral 
cavity. 
Analysis of the A. actinomycetemcomitans genome also revealed two genes, IsrB 
and rbsB, which encode putative periplasmic proteins related to the AI-2 receptor LuxP 
of V. harveyi (88, 195). The IsrB gene is within an operon that may be functionally 
related to the IsrACDBFGE operon of S. enterica serovar Typhimurium, which encodes 
an ABC-type transporter than internalizes AI-2. This operon is also located immediately 
downstream from a divergently transcribed operon, IsrRK, in S. enterica serovar 
Typhimurium that encodes a kinase (LsrK) that phosphorlyates AI-2 after its 
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internalization and a master regulator (LsrR) of the IsrACDBFGE operon. The IsrRK 
operon is also present upstream of the Isr operon in the A. actinomycetemcomitans 
genome (190). In addition, RbsB is similar to a protein expressed by E. coli. In A. 
actinomycetemcomitans, it is part of a five gene operon-rbsDACBK-which encodes an 
ABC-type transporter (RbsA and RbsC), a kinase (RbsK), and an enzyme (RbsD) that 
catalyzes the conversion of ribose from the pyran to the furan form (88). Therefore, there 
are two distinct mechanisms that A. actinomycetemcomitans may be able to utilize to 
detect and possibly internalize AI-2. In vitro competition assays demonstrated that LsrB 
and RbsB both are capable of binding AI-2 and competitively inhibiting the interaction of 
AI-2 with cell-associated LuxP. Interestingly, it was shown that RbsB has a higher 
affinity for A. actinomycetemcomitans AI-2 while LsrB interacted at a higher affinity 
with V. harveyi AI-2 (195), suggesting that RbsB and LsrB may differentially interact 
with AI-2 complexed with borate since the AI-2 recognized by V. harveyi is known to 
contain borate. Additionally, the difference between the kinetics of interaction with AI-2 
of each receptor may also allow A. actinomycetemcomitans to thrive in areas of low 
and/or high concentrations of the signaling molecule. Moreover, inactivation of either 
IsrB or rbsB resulted in a reduction of the ability of A. actinomycetemcomitans to deplete 
AI-2 from solution relative to the wild-type strain (190). Additionally, both the IsrS-
mutant strain and the rbsB- mutant strain had a reduction in biofilm formation similar to 
biofilm formation seen with the IuxS- mutant. Consistent with these results, inactivation 
of both IsrB and rbsB had an additive effect not only on the depletion rate of AI-2 by 
intact cells (190), but also on the ability of mutant strains to form biofilms (196). Taken 
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together, these results suggest that both RbsB and LsrB interact with AI-2, and that both 
the Lsr and Rbs transporters are capable of importing the signal into the bacterial cell. 
Alternative Pathways of AI-2-Dependent Quorum Sensing 
While the early events in AI-2-dependent signaling in A. actinomycetemcomitans 
have been elucidated as well as some of the genes regulated by AI-2, the events that 
connect detection and internalization to downstream gene expression have yet to be 
determined. Although proteins that were related to the Vibrio AI-2 receptor were readily 
identified, genes related to the dedicated two-component sensory system (LuxQ sensor, 
LuxU phosphorrelay, and LuxO response regulator proteins) have not been detected in A. 
actinomycetemcomitans. A. actinomycetemcomitans does possess several sensor kinases 
that exhibit similarity to the kinase domain of LuxQ and several response regulators that 
exhibit similarity to the DNA-binding domain of LuxO, but none of these proteins exhibit 
significant similarity to the LuxQ sensor domain which interacts with LuxP, or to the 
LuxO receiver domain which interacts with LuxU. Furthermore, there is no LuxU 
homolog in the genome of A. actinomycetemcomitans. The absence of this dedicated two-
component response circuit from Vibrio spp. in other organisms has led to the hypothesis 
that AI-2 does not function as a signaling molecule outside of the Vibrionales. Instead, 
AI-2 may only serve to function in metabolism in these organisms (43, 240). While this 
may be true for some organisms, the complex phenotypes associated with iuxS in other 
bacteria such as A. actinomycetemcomitans, and the biochemical complementation of 
these phenotypes by conditioned medium or synthetic AI-2 is not readily explained by 
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AI-2 being merely a metabolite; it instead suggests a more direct signaling function for 
AI-2. 
The exact mechanism through which the AI-2 signal information is transduced in 
organisms that do not express the LuxQ-LuxU-LuxO phosphorelay circuit, like A. 
actinomycetemcomitans, is not known. One potential possibility is that alternative AI-2 
circuits exist that depend on or require internalization of AI-2 via the Lsr (or Rbs) 
transporter. Taga et al (218) and Xavier et al (242) demonstrated that LrsK functions as a 
kinase that phosphorylates AI-2 in both S. enterica serovar Typhimurium and E. coli, 
respectively, and it is likely that a similar role is performed by LsrK in A. 
actinomycetemcomitans. More recently, it was shown that the product of the LsrK 
reaction with AI-2 is the phosphorylated form of AI-2 (5-phospho-4-hydroxy-2,3-
pentanedione) (242), suggesting that LsrB delivers R-THMF to the transporter for 
internalization, and once inside the bacterial cell, an equilibrium establishes between the 
steroisomeric cyclic forms of AI-2 and the linear form of DPD. Uptake of AI-2 occurs 
most efficiently during late exponential and stationery growth phases in several 
organisms, including A. actinomycetemcomitans, E. coli, and S. enterica serovar 
Typhimurium (54, 218, 241), indicating that a relatively high concentration of AI-2 is 
needed for LsrK activity and regulation of the Isr operon. On the other hand, AI-2 
appears to be also internalized by these organisms by lsr-independent mechanisms (88, 
124, 218), and at times when the expression of the Isr operon is low (62, 124). In A. 
actinomycetemcomitans, this internalization may occur via the rbs operon; and, in fact, 
AI-2 interacts with RbsB at a higher affinity than LsrB (195). Therefore, as suggested for 
E. coli by Li et aI, AI-2 signaling potentially occurs under conditions where LsrK-
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mediated phosphorylation rates and subsequent metabolism of AI-2 are low (124). Li et 
al also gave some of the first evidence that LsrR regulates gene expression on a more 
global basis in E. coli (124). To resolve the issue of LsrR regulating the lsrR operon as 
well as other genes outside of the lsr operon (genes associated with biofilm formation, 
e.g., genes for adhesions, polysaccharide export, and fimbriae), Li et al proposed that 
LsrR interacts with both unphosphorylated and phosphorylated forms of AI-2 (124). The 
primary regulator of the quorum sensing response that influences biofilm-associated 
genes is the complex of LsrR and unphosphorylated AI-2. The complex of LsrR and 
phosphorylated AI-2 controls the expression of the lsr transporter, essentially functioning 
as a trigger which terminates quorum sensing by initiating the rapid uptake and metabolic 
turnover of AI-2 (124). This hypothesis is interesting because it integrates a signaling 
function and metabolic activity to a single regulatory protein, and it also suggests that, 
analogous to the LuxR regulator which governs AI-mediated gene expression in V. 
harveyi, LsrR functions as the master regulator of the AI-2 response. 
Observations of AI-2-dependent quorum sensing in A. actinomycetemcomitans 
are consistent with the hypothesis proposed by Li et al (124) described above. RbsB 
functions as an AI-2 receptor, and the Rbs transporter may be a potential alternative 
pathway for Lsr-independent internalization of AI-2 (88, 195). In addition, the levels of 
AI-2 in cultures of A. actinomycetemcomitans are highest during mid- to late-exponential 
phase, and are quickly reduced when the cells enter stationary phase (54). This is in 
agreement with the stimulation of the activity of LsrK at high concentrations of AI-2, 
resulting in rapid phosphorylation of AI-2, the induction of the Lsr transporter and the 
metabolism of AI-2, and termination of putative LsrR-signaling activity. While E. coli 
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and A. actinomyctemcomitans may differ in their regulation of specific genes influenced 
by AI-2, biofilm formation is affected in both organisms (62, 196). Confirmation of this 
signaling mechanism in organisms, including A. actinomycetemcomitans, requires further 
identification of genes regulated by AI-2 as well as the interaction of LsrR with 
unphosphorylated AI-2. 
Furthermore, as mentioned earlier, the dedicated two-component signal 
transduction system that controls the cell density-dependent response of Vibrio spp. to 
AI-2 is conserved in few of these organisms that express LuxS and produce AI-2 (214). 
Thus, it may be possible that LuxS may primarily serve in the metabolic turnover of SAH 
and may not playa role in quorum sensing in all organisms; or, alternatively, functions in 
quorum sensing through different mechanisms. 
Treatment of Periodontal Disease 
Biofilm growth in the oral cavity is dependent upon AI-2-mediated intra- and 
interspecies signaling in A. actinomycetemcomitans (196). This signaling pathway may 
allow organisms-specifically pathogens-the ability to rapidly detect and adapt to 
changes in their local environment, confering a selective advantage that facilitates 
expansion of certain microbial popUlations. If virulence factors are regulated as part of 
this adaptive response, then the pathogenic potential of the biofilm may also rapidly 
change, thereby contributing to the onset or progression of disease. Therefore, quorum 
sensing circuits represent attractive targets for therapeutic intervention to control 
microbial growth as well as to control and prevent oral diseases associated with microbial 
biofilms, such as periodontitis. Quorum sensing has already been suggested to be a viable 
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target in diseases such as cystic fibrosis (79, 151), malaria (47), and other chronic 
infections (75, 151). Furthermore, naturally-occurring inhibitors of quorum sensing are 
being studied as drug candidates (75). 
The studies characterized in this dissertation further our understanding of AI-2 
quorum sensing in the dental pathogen A. actinomycetemcomitans both in vitro and in 
vivo, and lend a better understanding of the role of AI-2 dependent quorum sensing in 
periodontal pathogenesis. Overall, these studies define mechanistic differences in the 
known AI-2 signaling pathways that are present in the Vibrionales and in A. 
actinomycetemcomitans. Elucidating these differences will help develop novel therapies 
specific for A. actinomycetemcomitans-associated diseases, such as aggressive 
periodontitis. Furthermore, since many other species of bacteria communicate via AI-2 
(e.g. P. gingivalis), it is important to further define microbial quorum sensing in the oral 
cavity, where populational shifts in the oral biofilm, which result in overrepresentation of 
certain microbes, are strongly associated with the onset and progression of disease. 
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CHAPTER TWO: MATERIALS AND METHODS 
Bacterial strains and culture conditions. A. actinomycetemcomitans bacterial 
strains employed in this study are listed in Table 1 a. All other bacterial strains are listed 
in Table 1 b. A. actinomycetemcomitans JP2 and 652 are afimbriated, smooth colony 
morphotype strains and were grown at 37°C under microaerophilic conditions in Brain 
Heart Infusion broth (BHI; Bectin Dickinson and Company (BD), Sparks, Maryland) 
supplemented with 40 mg of NaHC03 (Sigma-Aldrich, St. Louis, MO) per liter. The 
luxS deficient strain of A. actinomycetemcomitans was grown as described above, but in 
medium supplemented with kanamycin (25 Ilg/ml; Sigma-Aldrich). The luxS- mutant, 
complemented with a plasmid borne copy of luxS, was grown in BHI supplemented with 
kanamycin (25 Ilg/ml) and streptomycin (50 Ilg/ml; Sigma-Aldrich). The A. 
actinomycetemcomitans lsrS- and rbsS- mutant strains were cultured in BHI 
supplemented with spectinomycin (50 Ilg/ml; Sigma-Aldrich) and kanamycin (25 Ilg/ml), 
respectively. The A. actinomycetemcomitans lsrS-rbsS- double mutant was cultured in 
BHI supplemented with kanamycin (25 Ilg/ml) and spectinomycin (50 Ilg/ml). The qseC 
mutant was grown in BHI supplemented with spectinomycin (50 Ilg/ml) , and the qseC 
complemented strain was cultured in BHI supplemented with kanamycin (25 Ilg/ml). 
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Table la. A. actinomyctemcomitans strains used in this study 
Bacterial Strain Description Source 
652 Wild-type; minimally leukotoxin strain (23) 
lsrn- IsrB- single-receptor mutant::spec (195) 
rbsB- rbsn- single-receptor mutant::kana (88) 
VJ 
>- IsrB-rbsB- lsrn-rbsn- double-receptor mutant: :spec/kana (195) 
qseC qseC mutant::spec This study 
qseCcomp qseC mutant complemented with pYGKqseC::kana This study 
lP2 Wild-type; highly leukotoxic strain (23) 
lP2-12 luxS- mutant::kana (54) 
lP2-121750 luxS- mutant complemented with plRD215luxS: :kana/strep (55) 
v.> 
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Table lb. Other bacterial strains used in this study 
Bacterial Strain Description 
E coli DHSa TqseC DHSa carrying pGEMTqseC::amp 
E coli DHSa TqseCcomp DHSa carrying pBSKQseC-spec::spec 
Ecoli pVT1461 Contains spectinomycin resistance cassette 
E coli DHSa pGEMT -toxin DHSa carrying pGEMT-toxin::amp 
E coli DHSa pET30a-toxin DHSa carrying pET30a-toxin::kana 
E coli BL21 pET30a-toxin BL21 carrying pET30a-toxin: :kana 
E coli DHSa pGEMT-TA DHSa carrying pGEMT-TA::amp 
E coli DHSa pET30A-TA DHSa carrying pET30a-T A: :kana 
E coli BL21 pET30a-T A BL21 carrying pET30a-TA::kana 
E coli DHSa pGEMT -toxine/p DHSa carrying pGEMT-toxine/p::amp 
E coli DHSa pBADgIIII A-toxine/p DHSa carrying pET30a-toxine/p 
E coli TOPI0 pBADgIIIIA -toxine/p BL21 carrying pET30a-toxine/p 
P. gingivalis 33277 Wild-type 
P. gingivalis luxS 33277 luxS mutant::ermF 

















Porphyromonas gingivalis strains were grown in reduced Trypticase Soy Broth 
(TSB; BD) supplemented with yeast extract (1 gram per liter; BD), menadione (1 J.lg per 
ml; Sigma-Aldrich), and hemin (5 J.lg per ml; Sigma-Aldrich). The medium was reduced 
for 24 hours under anaerobic conditions by equilibration in an atmosphere consisting of 
10% C02, 10% H2, and 80% N2. The P. gingivalis /uxS mutant (kindly supplied by R. 
Lamont, University of Florida, Gainesville, FL) was grown as described above, but the 
medium was supplemented with erythromycin (10 J.lg/ml; Sigma-Aldrich) immediately 
before inoculation. 
Vibrio harveyi BB170 (sensor r sensor 2"1 was a gift from B. Bassler (Princeton 
University) and was grown overnight in AB medium with aeration at 30°C (15). AB 
medium consists of 0.3 M NaCI, 50 roM MgS04, 0.2% Casamino Acids, 10 roM 
potassium phosphate (PH 7.0), 1 roM L-arginine, 2% glycerol, 1 J.lg per ml thiamine, and 
10 ng per ml riboflavin. E. coli strains were grown in Luria-Bertani (LB) medium (BD) 
with aeration at 37°C. E. coli strains containing plasmid pGEM-T or p YGK were cultured 
as described above in LB supplemented with 100 J.lg per ml ampicillin or 25 J.lg per ml 
kanamycin, respectively. 
Construction of qseC mutant and complemented strain. The A. 
actinomycetemcomitans qseBC operon was identified from the genomic sequence of 
strain HK1651 (Los Alamos National Laboratory, http://www.oralgen.lanl.gov/.) 
annotated as ygiX and qsec. However, it appeared that in the HK1651 genome the qseBC 
operon was disrupted by a gene rearrangement. This qseBC region was sequenced in 
strain 652 (the strain used to construct the mutant), and unlike HK1651, the qseBC 
33 
operon was indeed localized together. Thus, to construct the fragment for inactivation of 
qseC, part of the ygiX and qseC genes were amplified using genomic DNA of strain 652 
as the template with primers PI and P2 (Table 3a). The following PCR program was 
used: 94°C for 10 min for 1 cycle, and then 94°C for 30s, 60°C for Imin, and 72°C for 2 
min for 30 cycles. The PCR products were then ligated with pGEMT-Easy (Promega, 
Madison, WI) and transformed into E. coli DH5a. The resulting pGEMTQseC plasmid 
was purified from E. coli, cleaved by digesting with KpnIlBamHI and ligated into pBSK. 
The resulting plasmid, pBSKQseC, was then cleaved with BamHI and treated with 
Alkaline Phosphatase for insertion of a spectinomycin resistance cassette. The 
spectinomycin resistance cassette was obtained by PCR amplification using plasmid 
pVT1461 (kindly supplied by K. Mintz, University of Vermont) as template, with 
primers P3 and P4, and then ligated into pBSKQseC to create pBSKQseC-spec. This 
plasmid was then transformed into E. coli DH5a, and recombinant clones were confirmed 
by PCR using primers PI and P4. Purified pBSKQseC-spec plasmid was introduced into 
A. actinomycetemcomitans 652 by e1ectroporation with ampicillin-resistance and 
spectinomycin-resistance selection. The lack of QseC transcript in the mutant strain was 
confirmed by R T -PCR using primers P6 and P7. 
To make the qseC complemented strain, the entire qseC gene was amplified using 
652 genomic DNA as template with 5' qseC-comp-HindIII and 3' qseC-comp-BamHI 
primers. The leukotoxin promoter (ltx-pro) was also amplified from JP2 genomic DNA 
using the 5' ltx-pro-KpnI and 3' ltx-pro-HindIII primers. The PCR program was used: 
94°C for 10 min for 1 cycle, and then 94°C for 30s, 60°C for Imin, and 72°C for 2 min 




Table 2a. Primers* used in this study. 
Primers Primer Sequence (5' - 3') Target Gene Size (kbp) 
PI GGTACCTCGCCGTGGATTGGTTTACCGAC ygiX (5' primer) 1.030 
P2 GGATCCGGCGTTTATGCGACGGTTTG qseC (3' primer) 1.030 
P3 GGATCCATCGATTTTCGTTCGTG SpecR cassette 1.141 
P4 GGATCCCATATGCAAGGGTTTAT SpecR cassette 1.141 
P6 TAAGTGGAATAATTACAGCCTGCG qseC 0.139 
P7 TTGTTGTGCGTCAAACACTTGGTTC qseC 0.139 
5' qseC-comp-HindIII AAGCTTATGAAACTGAGTAAGTGG qseC 1.374 
3' qseC-comp-BamHI GGATCCCAACTGAATCTCTGCC qseC 1.374 
5' ltx-pro-KpnI GGTACCAATGAAAAAAAACAAAGCG Leukotoxin promoter 0.308 
3' ltx-pro-HindIII AAGCTTACTCGTTTTCCTTTTTCATTAG Leukotoxin promoter 0.308 
5' QseBC induction CGTTTGATTGTCACCTTGTCGCTG qseC 0.110 
3' QseBC induction TGTTGTGCGTCAAACACTTGGTTC qseC 0.110 
5' qseBC transcript CCGAAAATGGACGGGCTGGATGTGTTG ygiX (5' primer) 0.911 
3' qseBC transcript CGCCATTCGTCATCATCTTCCCGCAG qseC (3' primer) 0.911 
5' qseB sequence CCGGTTTCGCCGTGGATTGGTTTACC qseB 1.035 
3' q seB sequence GGCGTTTATGCGACGGTTTGCCACGT qseB 1.035 
5' qseC sequence CGGGTGGCTAATTAGAACGGGCAG qseC 1.525 
3' qseC sequence GCACGTCATGCGACCTTTCTATCAAAC qseC 1.525 
* Bold sequences indicate restriction enzyme sites to facilitate cloning into the appropriate shuttle vectors. 
v.> 
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Table 2b. Primers* used in this study. 
Primers Primer Sequence (5' - 3') Target Gene Size (kbp) 
5' qseC-aaseq GCGACGGCGAAAATGGGGAAAACTTTA qseC aa 130-1230 0.426 
3' qseC-aaseq CGGAGGTAAAACGCCGTTCACGCAATAA qseC aa 130-230 0.426 
5' 00696 CGGATTACTCGCCTCACAAGCG afuA 00696 0.318 
3' 0696 CCTTTGGTTTTTGCCGGATCGC afuA 00696 0.318 
5' 00795 GCGCAGAAAATCGGTGATGTCGTGG fecB 00795 0.317 
3' 00795 GCGATACTTTCCTGACGATAGTGTGC fecB 00795 0.317 
5' 5S rRNA GCGGGGATCCTGGCGGTGACCTACT 5S-2-rRNA 0.089 
3' 5S rRNA GCGATCTAGACCACCTGAAACCATACC 5S-2-rRNA 0.089 
5' AA00673-TAA CCATGGAATTGAGACAACAAGCAACGTTAG AA00673 0.263 
3' AA00673-TAA GGTACCTTAATAGTCCAATTCCTGCGGTAAA AA00673 0.263 
5' AA00673/672 CCATGGAATTGAGACAACAAGCAACGTTAG AA00673 (5' primer) 0.608 
3' AA00673/672 GGTACCTTATCGCAAAAGACGTTCACCA AA00672 (3' primer) 0.608 
5' AA00673-E/P CCATGGAATTGAGACAACAAGCAACGTTAG AA00673 0.263 
3' AA00673-E/P TCTAGATAGTCCAATTCCTGCGGTAAA AA00673 0.263 
5' TA transcript GGCAATTTACGTACAGTCCCTCAGTTTTCA AA00673 0.271 
3' T A transcript GGCGATATTTCCCGATTTCTTTTCCTTTCTT AA00672 0.271 
* Bold sequences indicate restriction enzyme sites to facilitate cloning into the appropriate shuttle vectors. 
pGEMT-Easy (Promega, Madison, WI) and transformed into E. coli DH5a. The resulting 
pGEMTQseCcomp and pGEMTltx-pro plasmids were purified from E. coli. The plasmid 
pGEMTQseCcomp was cleaved by digesting with HindUI and BamHI and the 
pGEMTltx-pro plasmid was cleaved by digesting with KpnI and HindU!. Both digested 
fragments-qseC gene and Itx promoter-were then ligated into p YGK. The resulting 
plasmid, p YGKqseC, was transformed into E. coli. The plasmid was then purified from 
an overnight culture of E. coli, and then electroporated into the qseC mutant for 
complementation. 
Partial purification of A. actinomycetemcomitans AI-2. An enriched fraction 
containing AI-2 from A. actinomycetemcomitans was produced as described by 
Sperandio et al. (209) for production of AI-2 from E. coli. Briefly, an overnight culture of 
A. actinomycetemcomitans cells were diluted 1 :20 into fresh medium, cultured to mid-
exponential phase (optical density, 0.3) at 37°C, and then harvested by centrifugation. 
AI-2 was obtained from a 7.2 ml aliquot of the conditioned medium. The culture 
supernatant was first filtered through a 0.22 J.lm-pore-size filter and then through a 
Centricon YM-3 3 kDa exclusion filter (Millipore, Bedford, MA). The resulting filtrate 
was lyophilized, suspended in 1 ml of cold 5 mM sodium phosphate buffer, pH 6.2, and 
chromatographed on a C18 Sep-Pak reverse-phase column (Waters Company, Milford, 
MA) according to the manufacturer's instructions. AI-2 activity was assessed by the 
induction of bioluminescence of Vibrio harveyi BB 170, and active fractions were 
lyophilized and stored at 4°C. 
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RNA isolation. Overnight cultures of the appropriate A. actinomycetemcomitans 
strains were diluted 1 :20 into fresh BHI medium with or without partially purified AI-2 
and incubated at 37°C until the mid-exponential growth phase (O.D. = 0.3) for RNA 
isolation. Total RNA was isolated from A. actinomycetemcomitans cells using the 5 
Prime PerfectPure RNA Cell & Tissue kit (5 Prime Inc., Gaithersburg, MD) according to 
the manufacturer's instructions. To ensure that the samples were free of contaminating 
genomic DNA, the RNA preparation was digested with RQ RNase-free DNase I 
(Promega Corporation, Madison, WI). The concentration and purity of each RNA sample 
were measured via spectrophotometry (ND-1000 Spectrophotometer, NanoDrop 
Technologies, Inc, Wilmington, DE) and was also assessed by gel electrophoresis. 
Samples were checked for contamination of genomic DNA by real-time PCR using A. 
actinomycetemcomitans 5s rRNA primers (Table 2b). RNA samples were considered free 
of significant genomic DNA if no amplification product was detected by real-time PCR 
after at least 30 cycles of amplification. RNA that was not immediately utilized for a 
reverse-transcription reaction was aliquoted into 1.5 ml Eppendorf tubes and stored at -
80°C until future use. 
eDNA synthesis and qPCR for qseBC gene expression. First-strand cDNA was 
prepared by using SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA) 
according to the manufacturer's instructions. Quantitative PCR (qPCR) was performed 
with the Smart Cycler system (Cepheid, Sunnyvale, CA) in a final reaction volume of 25 
III that contained 100 ng of cDNA, primers for qseC (5' QseB Induction and 3' QseB 
Induction; -71 IlM final concentration), and Ix FastStart SYBER Green Master (Roche, 
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Indianapolis, IN). The amplification conditions for qPCRs were as follows: denaturation 
at 95°C for 15 seconds, annealing at 55°C for 30 seconds, and elongation at 72°C for 30 
seconds for 35 cycles. The threshold cycle for each qPCR was determined from a second 
derivative plot of total fluorescence as a function of cycle number by using the software 
package supplied with the Smart Cycler system. All gene-specific threshold values were 
normalized against threshold values from primers specific for the A. 
actinomycetemcomitans 5S rRNA gene (~60 11M final concentration). qPCR reactions 
were carried out in triplicate with consistent results. Each qPCR end-point amplification 
product was visualized by electrophoresis on 2% agarose gels. 
eDNA synthesis and qPCR analysis of iron-uptake genes. qPCR was utilized 
to determine if qseC regulated the expression of genes involved in iron-uptake. RNA was 
isolated from A. actinomycetemcomitans strain 652, qseC- mutant, lsrB-rbsB- double-
receptor mutant, JP2, luxS- mutant, and luxS- complemented strain (see 'RNA isolation' 
section in Chapter 2) and cDNA was synthesized by using the qScript cDNA supermix 
(Quanta Biosciences) according to the manufacturer's instructions. The Smart Cycler 
system (Cepheid) was used for qPCR with the final reaction volume of 40 III that 
contained lOOng of cDNA, gene-specific primers (afuA 00696 andfecB 00795 ; 300 nM 
final concentration; Table 3b), and Ix PerfecCTa SYBR Green Fastmix (Quanta 
Biosciences). The amplification conditions for qPCR reactions were as follows: 
denaturation at 95°C for 15 seconds, annealing at 55°C for 30 seconds, and elongation at 
noc for 30 seconds for 35 cycles. The threshold cycle for each qPCR was determined 
from a second derivative plot of total fluorescence as a function of cycle number by using 
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the software package supplied with the Smart Cycler system. All gene-specific threshold 
values were normalized against threshold values from primers specific for the A. 
actinomycetemcomitans 5S rRNA gene (300 nM final concentration). qPCRs were 
carried out in triplicate with consistent results, and each qPCR end-point amplification 
product was visualized by electrophoresis on 2% agarose gels stained with ethidium 
bromide for 1 hour 15 minutes at 80 volts. 
Biofilm formation and analysis. A. actinomycetemcomitans biofilms were grown 
on a saliva-coated coverglass in a polycarbonate flow chamber (model FC81; Biosurface 
Technologies Corp, Bozeman, MT; chamber dimensions are 50.5 mm by 12.7 mm by 
2.54 mm) at a flow rate of 5.8 ml per hour at 25°C, essentially as described by Shao et al 
(196) Briefly, saliva was self-collected, filter-sterilized (pore size 0.22 ~m), and 
incubated with the coverglass (60 mm by 24 mm) for 30 minutes at 37°C. The saliva-
coated coverglass was then fixed into the flow chamber and washed with phosphate-
buffered saline (PBS; 100 mM NaH2P04, 150 mM NaCI) for 10 minutes at a flow rate of 
60 ml per hour using a peristaltic pump (Manostat Sarah cassette; Fisher Scientific, 
Pittsburgh, P A). Overnight cultures of A. actinomycetemcomitans were resuspended in 
PBS at an optical density of 0.5 at 600 nm and inoculated for one hour into the 
polycarbonate flow chamber. Flow cells were then washed with PBS for 30 minutes at a 
flow rate of 5.8 ml per hour. Bound cells were fed BHI medium and allowed to grow for 
60 hours at a flow rate of 5.8 ml per hour. The resulting biofilm was stained with 0.2 
mg/ml fluorescein isothiocyanate (FITC; Sigma-Aldrich) for 1 hour in the dark and then 
washed with PBS for 2 hours. 
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Biofilms were visualized usmg Olympus Fluoview FV500 confocal scanning 
laser microscope (Olympus, Pittsburgh, PA) under 600x magnification using an argon 
laser. Confocal images were captured from 9 randomly chosen frames from each flow 
chamber. Biofilm depth was determined by performing z-plane scans from 0 to 1 00 ~m 
above the cover glass surface. The total biofilm biomass was determined by integrating 
fluorescence intensity across the z-stack using the Fluoview FV500 software provided by 
Olympus. Biofilm depth, total biomass, and biofilm topology were also quantified 
utilizing COMSTAT image-processing software package (78). Biomass data were 
analyzed using a pairwise t test (Graphpad Software, Inc.) and expressed as the mean ± 
standard deviation calculated from all the frames obtained for a given biofilm. 
Experiments were carried out in triplicate. 
In vivo mouse periodontitis model. To assess A. actinomycetemcomitans 
virulence, a modification of the Baker mouse model of periodontitis was utilized (13). 
This model measures alveolar bone resorption, the clinical presentation of periodontitis in 
humans, as an outcome, and has been used previously to assess the virulence of P. 
gingivalis, another periodontal pathogen (168, 232). All animal procedures received 
Institutional Animal Care and Use Committee approval and were in accordance with 
Federal guidelines for the care and use of laboratory animals. Specific pathogen-free 
female Balb/cByJ mice (10 weeks old; Jackson Laboratory, Bar Harbor, ME) were orally 
infected with wild-type strain 652 or IsrB-, or rbsB-, or IsrB-rbsB- mutant strains; wild-
type strain 652 or qseC, or qseC complemented strain; wild-type strain JP2, or luxS", or 
luxS" complemented strains of A. actinomycetemcomitans. In some experiments, mice 
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were infected with wild-type 33277 or /uxS mutant strains of P. gingivalis. Briefly, prior 
to infection all animals were treated with sulfamethoxazole (final concentration of 800 
f..lg/ml; Sigma-Aldrich) and trimethoprim (final concentration of 400 f..lg/ml; Sigma-
Aldrich) in their water bottles ad libitum for 10 days to suppress the normal flora of the 
mouse oral cavity. After the 10 day antibiotic period, the mice were given regular 
drinking water without antibiotics for 4 days and then were orally infected a total of five 
times at 2-day intervals with lxl09 CFU/ml of bacteria resuspended in 2% 
carboxymethylcellulose (CMC; MP Biomedicals, Solon, OR) via a blunt-tipped syringe 
(Fisher Scientific, Pittsburgh, PA). Animals that served as the negative control group 
(sham-infected) received only 2% CMC without bacteria. Mice were euthanized with 
CO2 inhalation and cervical dislocation at 47 days after the last infection (for a total 
experiment time of70 days). 
Analysis of alveolar bone resportion. After euthanization, the mice were 
decapitated. The mouse heads were boiled for 15 minutes under 15 lb/in2 of pressure and, 
subsequently, defleshed. The skulls were then immersed in 3% hydrogen peroxide 
overnight at room temperature to remove any remaining musculature and washed with 
deioinized water. To ensure the teeth were cleaned of any residual bacteria andlor tissues, 
skulls were sonicated at 4 volts in 1 % bleach for 30 seconds, rinsed with water, and then 
gently brushed with toothpaste for 30 seconds. They were rinsed clean, swirled in 
Listerine for 30 seconds, and then once again sonicated at 4 volts in 1 % bleach and rinsed 
clean with deionized water. The cleaned teeth were stained for 30 seconds with 1 % 
Methylene Blue (Ricca Chemical Company, Arlington, TX) and rinsed with deionized 
42 
water to remove excess dye. Skulls were allowed to air-dry prior to measurement of the 
alveolar bone. 
To measure loss of alveolar bone, the distance from the Cemento-Enamel 
Junction (CEJ) to the Alveolar Bone Crest (ABC) was measured at 7 sites on the buccal 
side of the right and left maxillary molars (for a total of 14 measurements per animal), 
utilizing a dissecting microscope fitted with a video image marker measurement system 
(model VIA-170K; Fryer, Huntley, IL) standardized to give measurements in millimeters. 
Alveolar bone loss was calculated by subtracting the 14-site mean sum total CEJ :ABC 
distance of each experimental group from the mean sum total of the CEJ :ABC distance of 
the sham-infected group. Results were expressed as millimeter change in bone, and 
negative values indicate bone loss compared with sham-infected controls. 
Purification of RNA by centrifugation in cesium chloride gradients. 
Overnight cultures of the appropriate A. actinomycetemcomitans strains were diluted 1: 1 0 
into fresh BHI medium incubated at 37°C until the mid-exponential growth phase 
(OD600nm = 0.3) for RNA isolation. Total RNA was isolated from 200 ml of A. 
actinomycetemcomitans cells using the cesium chloride density gradient centrifugation 
method similar to Reddy et al (174). Initially, cultures were put on ice to stop cellular 
activities, and 1120 volume of Buffer A (200 mM Tris-HCI (Sigma-Aldrich) (PH 8.0) , 20 
mM EDT A (Sigma-Aldrich), 20 mM sodium azide (Sigma-Aldrich), 20 mM 
aurintricarboxylic acid (Sigma-Aldrich) was added. The cultures were then centrifuged at 
8,000 x g for 15 minutes. The resulting cell pellet was resuspended in 5 ml of STET 
buffer (50 mM Tris-HCI (PH 7.0), 8% sucrose (Sigma-Aldrich), 5% Triton X-100 
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(Sigma-Aldrich), 5 mM EDT A). Cell suspensions were extracted with equal volumes of 
phenol and chloroform, and nucleic acids were precipitated with 1110 volume of sodium 
acetate and two volumes of ethanol. The nucleic acid pellet was resuspended in 2 ml of 
diethyl pyrocarbonate (DEPC)-treated water, and extracted and precipitated twice more 
as described above. The resulting nucleic acid pellet was resuspended in 2 ml of DEPC-
treated water containing 1 g of cesium chloride (RPI, Mount Prospect, IL), layered onto a 
2.S ml cushion of 5.7 M cesium chloride-S mM EDTA, and centrifuged at 105, 000 x g 
for 18 hours. The RNA pellets were then suspended in 1 ml of DEPC-treated water, 
precipitated with ethanol, and finally suspended in 1 ml of nuclease-free water (EMD 
chemicals, Gibbstown, NJ). The concentration and purity of each RNA sample were 
measured via spectrophotometry (ND-1000 Spectrophotometer) and was also assessed by 
gel electrophoresis. RNA samples that had contaminating DNA were digested withRQ 
RNase-free DNase I (Promega). RNA samples were considered free of significant 
genomic DNA if no amplification product was detected by real-time PCR after at least 30 
cycles of amplification using A. actinomycetemcomitans 5s rRNA primers. RNA that 
was not immediately utilized for a reverse-transcription reaction was aliquoted into 1.S 
ml eppendorf tubes and stored at -80°C until future use. 
Determination of ORFs Aa00672-Aa00673 operon structure. In order to 
determine if AA00672 and AA00673 were co-transcribed in the same operon, cDNA was 
synthesized by using qScript cDNA supermix (Quanta Biosciences, Gaithersburg, MD) 
and RNA previously isolated from A. actinomycetemcomitans strain 652 (see 'RNA 
isolation' section in Chapter 2). A reverse-transcription PCR (RT-PCR) reaction was then 
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set-up as follows: 100ng of cDNA, Ix Platinum PCR supermix (Sigma-Aldrich), primers 
designed to span both AA00673 and AA00672 (TA-transcript primers-see Table 3b). 
The amplification conditions for the RT-PCR reaction was as follows: denaturation at 
95°C for 30 seconds, annealing at 55°C for 30 seconds, and elongation at noc for 30 
seconds for 30 cycles. Resulting PCR products were resolved on a 2% agarose gel stained 
with ethidium bromide for 1 hour 15 minutes at 80 volts. 
Regulation of ORFs Aa00672-Aa00673 by AI-2. qPCR was utilized to 
determine if AI-2 regulated the expression of AA00672-AA00673. RNA was isolated 
from A. actinomycetemcomitans strain 652, qseC mutant, and /srB-rbsg double-receptor 
mutant (see 'RNA isolation' section in Chapter 2) and cDNA was synthesized by using 
the qScript cDNA supermix (Quanta Biosciences) according to the manufacturer's 
instructions. The cDNA was amplified using the Smart Cycler system (Cepheid) in a final 
reaction volume of 40111 that contained lOOng of cDNA, gene-specific primers (TA-
transcript primers; 300 nM final concentration), and Ix PerfecCTa SYBR Green Fastmix 
(Quanta Biosciences). The amplification conditions for qPCR reactions were as follows: 
denaturation at 95°C for 15 seconds, annealing at 55°C for 30 seconds, and elongation at 
noc for 30 seconds for 35 cycles. The threshold cycle for each real-time PCR was 
determined from a second derivative plot of total fluorescence as a function of cycle 
number by using the software package supplied with the Smart Cycler system. All gene-
specific threshold values were normalized against threshold values from primers specific 
for the A. actinomycetemcomitans 5S rRNA gene (300 nM final concentration). qPCRs 
were carried out in triplicate with consistent results. Each qPCR end-point amplification 
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product was visualized by electrophoresis on 2% agarose gels stained with ethidium 
bromide for 1 hour 15 minutes at 80 volts. 
Construction of Aa00673 and Aa00672-Aa00673 IPTG-inducible vectors. To 
construct the fragment that would be cloned into the inducible vector, the entire 
AA00673 gene was amplified using genomic DNA of strain 652 as the template with 
primers 5' AA00673-TAA and 3' AA006n-TAA (Table 3). The following PCR program 
was used: 95°C for 10 min for 1 cycle, and then 95°C for 30s, 55°C for 30 seconds, and 
noc for 30 seconds for 35 cycles. The PCR products were then ligated with pGEMT-
Easy (Promega, Madison, WI) overnight at 4°C and then transformed into E. coli DH5u. 
The resulting pGEMT -AA00673 plasmid was purified from E. coli, cleaved by digesting 
with KpnIlNcol and ligated into the IPTG-inducible pET30a vector overnight at 4°C and 
then transformed into E. coli DH5u. Potential clones were confirmed by purifying and 
digesting the resulting plasmid, pET30a-AA00673, with KpnIlNcoI. Once the pET30a-
AA00673 construct was confirmed to be correct, the plasmid was transformed into E. coli 
BL21. Recombinant clones were confirmed by PCR using primers 5' AA00673-TAA and 
3' AA00673-TAA and also by purifying the plasmid from BL21 clones and digesting 
with KpnIlNcoI. Clones which carried the correct construct were stored at -80°C for 
future use. 
The construct for AA00673-AA00672 was made in the same way, except the 
entire region encoding AA00673 thru AA00672 (see Table 3 for sequences) was 
amplified from the genomic DNA of A. actinomycetemcomitans strain 652 by using the 
following PCR program: 95°C for 10 min for 1 cycle, and then 95°C for 30s, 55°C for 30 
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seconds, and 72°C for 1 minute for 35 cycles. The construct was then made following the 
same procedure as the pET30a-AA00673 construct. 
Growth curve of after induction of Aa00673 or Aa00672-Aa00673. Overnight cultures 
of E. coli BL21 containing the IPTG-inducible pET30a vector with the toxin (pET40a-
AA00673) or the pET30a vector with the TA system (pET30a-AA00673-AA00672) were 
inoculated (l: 10 dilution) into fresh LB medium. Once the OD600nm reached 0.4, the 
cultures were induced by adding 1 mM IPTG. Control cultures were not induced. The 
optical density was taken every 30 minutes after induction to determine the growth. 
Growth curves were completed in triplicates. Results are mean ± standard deviations. 
Cell viability after removal of inducer. In the assay where cell viability was 
determined, two hours after the cultures were induced, IPTG was removed by washing 
three times with LB medium in the same volume as the culture. Cultures were then 
resuspended in LB medium (volume equal to that before washing) and incubated at 37°C. 
Growth was measured every 30 minutes after removal of IPTG. At certain time points 
during the growth curve, aliquots were taken and appropriate dilutions were plates on 
LBkan plates. Plates were incubated at 37°C overnight. Colonies were counted after 24 
hours, and the number of Colony Forming Units per ml (CFU/ml) were calculated. 
Results are mean ± standard deviations. 
Construction of vector with Aa00673 for protein production. The toxin-
expressing plasmid was constructed as follows. The primers (5' AA00673-E/P and 3' 
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AA00673-E/P) used to amplify the toxin (AA00673) gene were designed with restriction 
enzymes (Ncol and Xbal, respectively) engineered into the 5' end to allow for easier 
cloning into the expression vector. The entire AA00673 gene was amplified using 
genomic DNA from A. actinomycetemcomitans strain 652 as the template. The following 
PCR program was used: 95°C for 10 min for 1 cycle, and then 95°C for 30s, 55°C for 30 
seconds, and 72°C for 30 seconds for 35 cycles. The purified PCR product was then 
ligated into pGEMT-Easy (Promega) overnight at 4°C and then transformed into E. coli 
DH5u. The resulting pGEMT-AA00673-E/P plasmid and pBAD/gIIIA was cleaved by 
digesting with NcoIIXbaI; fragments were purified by gel electrophoresis on a 1 % gel and 
ligated with T4 ligase overnight at 4°C. After transformation into E. coli DH5u, plasmid 
was purified from potential clones and digested with NcollXbal to digest the validity of 
the construct. The correct plasmid, pBADgIIIIA-AA00673-E/P, was then were 
transformed into chemically-competent E. coli TOPIO. Recombinant clones were 
confirmed by PCR using primers 5' AA00673-E/P and 3' AA00673-E/P and also by 
purifying the plasmid from TOPIO clones and digesting with NcollXbal. Clones which 
carried the correct construct were stored at -80°C for future use. 
Expression and purification of toxin protein. An overnight culture of E. coli 
TOPIO containing the pBAD/gIIIA-AA00673-E/P construct was inoculated (1 :20 
dilution) into fresh LB medium. The culture were incubated at 37°C in a shaker and was 
induced with 0.2% arabinose once the OD600nrn reached 0.8. Growth was continued for 
another 4 hours, after which time the cells were harvested, centrifuged for 15 minutes at 
8,000 x g, and placed at -20°C overnight. The cell pellet was thawed on ice, resuspended 
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in 10 mM Tris (pH 8.0) containing 10 mg/ml oflysozyme, sonicated three times on ice, 
and centrifuged at 10,000 x g to remove cellular debris. The supernatant was collected 
into a clean 50 ml tube. The toxin was purified from the resulting supernatant by affinity 
chromatography over a copper resin (HisTrap resin; GE Healthcare, Piscataway, NJ). The 
column was first washed with 25ml of binding buffer (0.02 M sodium phosphate, 0.5 M 
NaCI, 20 mM imidazole, pH 7.2). The protein extract was then loaded, and the column 
was subsequently washed with 25 ml of binding buffer and 10ml of 100 mM imidazole 
elution buffer (0.02 M sodium phosphate, 0.5 M NaCl, 100 mM imidazole, pH 7.2). 
Bound toxin was eluted with a 10 ml of 500 mM imidazole elution buffer (0.02 M 
sodium phosphate, 0.5 M NaCI, 500 mM imidazole, pH 7.2). Eluted protein was 
collected into a clean 15 ml tube. Eluted protein was dialyzed three times against 25 mM 
phosphate buffer (1.25 mM Na2HP04; 1.25 mM NaH2P04) with 50 mM NaCI: twice for 
4 hours at 4°C and once overnight at 4°C. An aliquot of the dialyzed protein was used to 
determine protein concentration using the BCA Protein assay (Pierce, Rockford, IL). 
Purity of the dialyzed protein was assessed by Coomassie blue staining after 
polyacrylamide gel electrophoresis on a 4-12% Bis-Tris NuP AGE gradient gel 
(Invitrogen). Confirmation of the correct protein construct with His-Tag was confirmed 
by a western blot. Murine monoclonal anti-polyHistidine antibody (Sigma-Aldrich), 
which recognizes the His-Tag, was used as the primary antibody, and Goat anti-mouse 
IgG conjugated with horseradish Peroxidase (Fisher), which recognizes the mouse 
primary antibody, was used as the secondary antibody. Diaminobenzidine (Sigma-
Aldrich) was used to develop the blot and visualize the antibody-protein complex. 
Dialyzed protein that was not immediately utilized was lyophilized to dryness. 
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Sequencing of ygiX and operon structure. The constructs containing ygiX 
(qseB) and qseC used for sequencing were constructed as follows. Primers were designed 
(Table 3) to amplify the region from ygiX through qseC, the qseB gene, the qseC gene, 
and the qseC gene amino acids 130-230. Each fragment was amplified from the genome 
of A. actinomycetemcomitans strain 652 using the following PCR program: 95°C for 10 
min for 1 cycle, and then 95°C for 30s, 55°C for 30 seconds, and 72°C for 1.5 minutes 
for 35 cycles. The purified PCR product was then ligated into pGEMT -Easy (promega) 
overnight at 4°C and then transformed into E. coli DH5a. The resulting plasmids were 
purified from E. coli and sent to the DNA sequencing core facility at the University of 
Louisville to be sequenced with T7 and SP6 primers. The operon structure was elucidated 
by digesting out sequence of the pGEM-T easy vector and assembling the sequence of the 
ygiX-qseC region that was returned from the DNA core facility. Sequences were also 
referenced against the genome of A. actinomycetemcomitans strain D 11 S available from 
the National Center for Biotechnology Information (NCBI) website 
(http://w\\'\v.ncbi.nlm.nih.gov/gene?Db=genome&Cmd=ShowDetailView&TermToSearc 
h=25 3 2 7 &GeneSearch ). 
RNase activity of AA00673. In order to determine the RNase activity of 
AA00673, a Transcript RNA marker (a mixture of 7 defined RNA transcripts, ranging 
from 0.1 - 1 kb; Sigma-Aldrich) was used. The RNA marker was incubated at 70°C for 5 
minutes to denature any secondary structure that may have formed. The RNA marker was 
then incubated with increasing amounts of affinity purified His-AA00673 (dialyzed 
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protein but not lyphophilized) in 10 mM Tris-HCI (pH 8.0) containing 1 mM 
dithiothreitol at 37°C for 15 minutes. The reactions were separated on a 1.2% agarose gel 
stained with ethidium bromide for 1 hour. 
Statistical Analysis. Data was evaluated by ANOV A and the Dunn multiple-
comparison test using the InStat program (Graphpad). Two-tailed t tests were also 
performed where appropriate (comparison of two groups only). Statistical differences 
were considered significant at the level ofp < 0.05. 
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CHAPTER THREE: AUTOINDUCER-2 AND QSEC CONTROL BIOFILM AND 
IN VIVO VIRULENCE IN AGGREGATIBACTER ACTINOMYCETEMCOMITANS 
Introduction 
Dental plaque is a complex and dynamic microbial community that forms as a 
biofilm on the surfaces of teeth and oral tissues (110, 118, 164, 237). It is comprised of 
over 700 species of bacteria (1, 110, 116, 118, 164, 237) and is the prime etiological 
agent of three common human oral diseases: dental caries, gingivitis, and periodontal 
disease (131, 132, 205). Major shifts in microbial populations within the oral biofilm 
have been associated with the progression of disease, as diseased sites often have 
increased populations of pathogenic species relative to healthy sites in the oral cavity 
(131-133). The host and/or microbial signals that contribute to the populational shifts 
associated with disease are still unknown. However, the oral cavity is subject to continual 
environmental flux, including changes in pH, temperature, osmolarity and nutrient 
supply, and it is possible that these stresses contribute in part to microbial population 
shifts in the biofilm. It is clear that oral bacteria rapidly detect environmental fluctuations 
and respond appropriately, allowing them to successfully coexist and thrive in the oral 
cavity (2, 87, 133). 
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Both intra- and interspecies communication is known to occur between bacteria, 
and these signaling processes potentially enable the organisms to coordinate their 
behavior and function by regulating gene expression as a community. One mechanism of 
communication, termed quorum sensing, is a cell density-dependent response (116, 140, 
190, 253), which in Gram-negative bacteria is mediated by the production, release, and 
detection of soluble signal molecules called autoinducers. A variety of chemical species 
function as autoinducers, including acylated homoserine lactones (74, 162), quinolone 
derivatives (166), and furan derivatives (e.g. autoinducer-2 [AI-2]) (140, 190, 236, 240). 
As a population of bacteria expands, the external concentration of the autoinducer 
increases until a threshold is attained, at which point a signal transduction cascade is 
initiated that alters gene expression and behavior of the microbial community. Quorum 
sensing has been shown to control cell-density dependent behaviors such as the 
expression of virulence factors, biofilm formation, and iron acquisition in a variety of 
organisms (14, 74, 237, 238). Thus, it has been suggested that quorum sensing may 
allow bacteria in a biofilm to react coordinately as a multi-cellular organism to changes in 
the external environment. 
The dental pathogen Aggregatibacter actinomycetemcomitans, a Gram-negative 
organism associated with aggressive forms of periodontitis and other systemic infections 
(20, 159, 203, 250), possesses an AI-2-dependent quorum sensing system (54). AI-2 
produced by A. actinomycetemcomitans regulates expression of virulence factors, biofilm 
formation, and iron uptake and also influences the planktonic growth of the organism 
under iron limitation (55, 188, 196). A. actinomycetemcomitans possesses two 
periplasmic AI-2 receptors, LsrB and RbsB, both of which are linked to ABC transporters 
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(88, 195), suggesting that A. actinomycetemcomitans may import AI-2. However, exactly 
how the detection and/or importation of AI-2 is linked to downstream gene regulation 
remains to be determined. Previous micro array experiments identified the QseBC two-
component system as being regulated by LuxS in A. actinomycetemcomitans (Demuth, 
D.R., unpublished). In E. coli, the QseBC two-component signal transduction system has 
been suggested to regulate biofilm formation (62), and A. actinomycetemcomitans 
contains an operon that displays 70-80% sequence similarity to QseBC of E. coli. QseBC 
is also similar to the feuPQ two-component system that regulates iron uptake in 
Rhizobium leguminosarum, Sinorhizobium meliloti, and Brucella suis (46), and iron 
acquisition is known to be regulated by AI-2 (55) and dramatically influences biofilm 
formation (177, 178). In this study, we show that qseBC is part of the AI-2 regulon, and 
its induction requires a functional AI-2 receptor. The qseBC operon also contributes to 
biofilm formation and virulence of A. actinomycetemcomitans, since inactivation of qseC 
results in reduced biofilm growth and attenuates virulence in vivo. These results suggest 
that QseBC may couple the detection and importation of AI-2 to the downstream 
regulation of gene expression that controls these processes. 
Results 
AI-2 is required for induction of QseBC in A. actinomycetemcomitans: 
In E. coli, the QseBC two-component system is induced by AI-2, and 
furthermore, is part of the AI-2-dependent response circuit that controls biofilm growth 
(62). The genome of A. actinomycetemcomitans encodes a two-component system that is 








Figure 7. Structure of QseBC in A. actinomycetemcomitans 652. A) The ygiX 
and qseC genes in A. actinomycetemcomitans strain 652 overlap by 11 bp. B) RT-
peR using primers targeting the 3' end of ygiX and the 5' end of qseC, indicates 
that the ygiX and qseC genes are co-expressed in an operon. Lane 1: 2-log ladder; 2: 
100 ng Total 652 RNA (cDNA); 3: 100ng of No-Reverse-Transcriptase control, 
which is a cDNA synthesis reaction which includes RNA, but no reverse 
transcriptase; 4: 250 ng Total 652 RNA (cDNA); 5: 250 ng of No-Reverse-
Transcriptase control; 6: Positive control, 652 genomic DNA; 7: Negative control, 
which has water as the template. 
a sensor histidine kinase (qseC) and response regulator (ygiX) of a two component signal 
transduction system (www.oralgen.lanl.gov). In strain 652, the ygiX and qseC genes 
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Figure 8. Sequence identity of QseB and QseC. A) The amino acid deductions of 
A. actinomycetemcomitans strain 652 ygiX gene display significant sequence 
identify with qseB from E. coli 0157:H7 as analyzed by blastx. Shown is the 5' 
end of the ygiX sequence in A. actinomycetemcomitans, which exhibits sequence 
identify (82/141 (58%» in E. coli from amino acid 78 to 218. Sequences from 3' 
end of ygiX show same levels of sequence identity to E. coli 0157:H7. B) The 
amino acid deductions of A. actinomycetemcomitans strain 652 qseC gene display 
significant sequence identify (119/208 (57%» with qseC from E. coli 0157:H7 as 
analyzed by blastx. Shown is the 3' end of the qseC sequence in A. 
actinomycetemcomitans, which exhibits sequence identify in E. coli from amino 
acid 223 to 437. Sequences from 5' end of qseC show the same levels of sequence 
identity to E. coli 0157:H7. 
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operon (Figure 7B). The deduced amino acid sequences of ygiX and qseC from strain 652 
exhibit significant sequence identity with QseB and QseC from E. coli (Figure 8A and 
Figure 8B, respectively). 
To determine if AI-2 regulates the putative QseBC two-component system in A. 
actinomycetemcomitans, the expression of qseC was examined using real-time PCR with 
RNA isolated from overnight cultures of the luxS mutant grown in medium alone or in 
medium supplemented with partially purified AI-2. As shown in Table 3, the presence of 
AI-2 in the growth medium resulted in a 14.5-fold induction of qseC. As a control, 
cultures were also grown in medium supplemented with conditioned culture fluid 
obtained from the luxS strain that was subjected to the same purification scheme used to 
obtain the AI-2 samples. No increase in qseC expression was observed under these 
Table 3. QseBC two-component system is influenced by AI-2. 
Strain delta (T) 
1 
delta (delta T) Fold Induction 
JP2-12 -3.1 ± 0.6 0.11 ± 0.04 1.0 
JP2-12 + AI-2 -0.66 ± 0.2 1.52 ± 0.3 14.5 ± 4.3 
2 
JP2-12 + mock 3.6 ± 0.05 0.08 ± 0.01 0.8 ± 0.3 
IsrB-rbsB-
3 3.2 ± 0.35 0.09 ± 0.13 0.95 ± 0.2 
I Delta T was calculated by subtracting the cycle threshold determined for the qseC 
reaction from the Ct ofthe 5S rRNA control. 
2 Mock control represents culture fluid from the luxS strain subjected to the 
purification scheme used to partially purify AI-2. 
3 This strain contains a functional copy of luxS and produces but cannot respond to 
AI-2. 
conditions. In addition, the induction of qseC did not occur in the IsrB-rbsB- strain of A. 
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actinomycetemcomitans, which lacks the AI-2 receptors but which can still produce AI-2. 
This suggests that the QseBC two-component system in A. actinomycetemcomitans is 
regulated by AI-2 and may be linked to the detection and/or importation of AI-2 by the 
AI-2 receptors. 
Inactivation of qseC influences biofilm formation in A. actinomycetemcomitans: 
Previous studies demonstrated that biofilm formation by A. 
actinomycetemcomitans was dependent on AI-2-mediated quorum sensing (l96), but how 
the initial detection of the AI-2 signal leads to downstream regulation of gene expression 
that influences biofilm growth was not determined. To determine if QseBC plays a role in 
regulating biofilm growth, wild-type, qseC, and qseC complemented strains of A. 
actinomycetemcomitans were cultured in flow cells as described in Chapter 2. 
Representative images of the biofilms formed by each of these strains are shown in 
Figure 9A and illustrate that inactivation of qseC resulted in a significant reduction in 
biofilm growth. Complementation of the mutant with a plasmid-borne copy of qseC 
restored biofilm growth to wild-type levels. Analysis of the biofilms using COMSTAT is 
shown in Figure 9B. The total biomass (p < 0.03), average depth (p < 0.02), and 
maximum depth (p < 0.004) of biofilms formed by the qseC mutant were significantly 
reduced relative to wild-type (see Figure 9B). All biofilm growth parameters were 
restored to wild-type levels in the complemented strain. Indeed, biomass and average 
biofilm depth for the complemented strain were greater than wild-type, which may reflect 
gene dosage as qseC is expressed from a multi-copy plasmid in the complemented 
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A. 
652 qseC qseCcomp 
B. 
Strain 





) C .... m) C .... m) 
652 3.86 ± .83 5.77 ± 0.92 37 ±1.41 
qseC 0.32 ± 0.057 1 0.4 ± 0.16 3 14 ± 1.41 5 
qseCcomp 8.61 ± 0.23 2 13.35 ± 0.72 4 38.2 ± 0.71 
Biomass was detennined using the COMSTAT package ofbiofilm analysis software. 
1 P < 0.0265 2 P < 0.0160 3 P < 0.0147 4 P < 0.0116 5 P < 0.0038 
Figure 9. qseC is necessary for bionlm growth in A. actinomycetemcomitans. A) 
Representative confocal images (in the x/y plane) of 60-hour biofilms fonned by wild-
type A. actinomycetemcomitans (652), qseC, and qseC complemented strains. The 
resulting biofilms were quantified using the COMSTAT program. B) Values for 
microbial biomass, average biofilm depth, and maximum biofilm depth were 
determined using COMSTAT image-processing software as described in the Materials 
and Methods. At least nine individual microscopic frames were analyzed for -each 
biofilm experiment, and three independent biofilm experiments were carried out for 
each strain. 
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Table 4a. Expression of the periplasmic iron-com pound-binding protein 
afuA 00696 in the qseC mutant. 
Strain delta TI delta (delta T) Fold Change 
652 1.34 + 0.44 0.4 + 0.13 1.0 
qseC -0.15 + 0.2 1.11 +0.15 2.8 + 0.79 
qseCcomp 2.50 + 0.31 0.18 + 0.04 0.44 + 0.14 
1 delta T was calculated by subtracting the cycle threshold (Ct) determined for 
the 00696 reaction from the Ct of the 5S rRNA control. 
Table 4b. Expression of the perplasmic iron-compound-binding protein 
afuA 00696 in the iuxS mutant. 
Strain delta TI delta (delta T) Fold Change 
652 13.14 + 0.08 0.0001 + 6.3E-06 1.0 
luxS 9.45+0.14 0.001 + 0.00001 12.83 + 1.12 
luxScomp 14.5 + 0.17 4.3E-05 + 5.2E-06 0.40 + 0.07 
1 delta T was calculated by subtracting the cycle threshold (Ct) determined for 
the afuA 00696 reaction from the Ct of the 5S rRNA control. 
Table 4c. Expression of the putative periplasmic iron-dicitrate-binding 
proteinfecB 00795 in the qseC mutant. 
Strain delta TI delta (delta T) Fold Change 
652 6.64 + 0.08 0.01 + 0.0005 1.0 
qseC 4.97 + 0.06 0.03 + 0.0014 3.18+0.31 
qseCcomp 7.42 + 0.05 0.01 + 0.0001 0.58 + 0.01 
1 delta T was calculated by subtracting the cycle threshold (Ct) determined for 
thefecB 00795 reaction from the Ct of the 5S rRNA control. 
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orgamsm. These results suggest that QseC controls biofilm formation by A. 
actinomycetemcomitans. 
Inactivation of qseC influences iron acquisition genes in A. 
actinomycetemcomitans: 
Fong et al has previously shown that AI-2 regulates the planktonic growth of A. 
actinomycetemcomitans under iron-limitation (54,55). It was also shown that expression 
of genes encoding putative A. actinomycetemcomitans receptors for heme, transferrin, 
and hemoglobin was down-regulated while genes for an ABC-type transporter, ferric 
citrate operon, and another operon encoding a putative enterobactin receptor were up-
regulated (55). 
Although AI-2 appears to regulate iron uptake in A. actinomycetemcomitans, the 
mechanism of AI-2-mediated transcriptional regulation of iron acquisition genes has not 
yet been established. One potential component that may be involved in the regulation of 
iron-uptake genes in A. actinomycetemcomitans is the QseBC two-component system. 
QseBC shares sequence similarity with FeuPQ two-component system, which is known 
to regulate iron uptake in other bacteria, such as Sinorhizobium and Brucella suis (46). To 
determine if QseBC functions in the transcriptional regulation of iron acquisition genes in 
A. actinomycetemcomitans, the expression of iron-uptake genes in wild-type and QseC-
deficient strains were compared by using real-time PCR. Table 4a illustrates that the 
expression of a putative periplasmic iron-compound-binding protein (afuA 00696) is up-
regulated 2.8 fold in the qseC mutant and is up-regulated 12.8-fold in the luxS- mutant 
(Table 4b). Expression of fecB 00795, a putative ferric citrate transport protein, is also 
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up-regulated in a QseC-deficient background (Table 4c). Furthermore, comparison of the 
expression of iron-uptake genes in wild-type and the qseC mutant indicated that some, 
but not all luxS-regulated iron-uptake genes are regulated by QseBC (Table 5), 
suggesting that the /uxS and qseBC regulons may overlap. Thus, qseBC may regulate a 
collection of the AI-2-regulated iron-acquisition genes in A. actinomycetemcomitans. 
Table 5. Expression of other AI-2-regulated iron genes in the qseC mutant. 
Strain fecB 2380 afeA 2549 afuA 1048 hasR 2782 pfeA 2151 
652 1.0 1.0 1.0 1.0 1.0 
qseC 0.50 + 0.63 0.84 + 0.07 0.51 + 0.09 0.40 + 0.04 0.31 + 0.08 
qseCcomp 0.07 + 0.17 0.01 + 0.003 0.03 + 0.01 0.26 + 0.04 0.29 + 0.003 
The A. actinomycetemcomitans qseC mutant and AI-2-receptor mutants are less 
virulent in a murine model of periodontitis. 
The ability of A. actinomycetemcomitans to acquire iron and grow in a biofilm is 
essential for its survival in the oral cavity and is associated with virulence. Our previous 
studies showed that AI-2-dependent quorum sensing (196) and qseC (described above) 
are essential components that regulate biofilm formation. To determine if AI-2 and qseC 
influence A. actinomycetemcomitans virulence, we utilized a murine model of 
periodontitis (13) in which mice were orally infected with 1x109 CFU/ml of the wild-type 
strain, or strains lacking either QseC or the AI-2 receptors. As a control, sham-infected 
mice were infected only with CMC, the vehicle used to deliver the bacterial suspensions. 
Alveolar bone loss, one of the clinical outcomes of periodontal disease in humans, was 
then measured forty-seven days after the last infection. As shown in Figure lOA, mice 
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Figure 10. qseC is necessary for the in vivo virulence of A. 
actinomycetemcomitans. A) The AI-2-receptor mutants caused significantly less 
alveolar bone resorption relative to wild-type. Infection with either the /srB- or rbsB-
mutant induced more bone loss than sham-infected mice, but significantly less than 
the wild-type. The /srB-rbsB- mutant induced bone loss comparable to that observed 
in sham-infected animals. The asterisks indicate statistical significant difference 
relative to sham; ~ is significant relative to wild-type; and D is significant relative to 
the rbsB- strain. Values are ± SEM. N = 6. B) Infection of mice with the qseC 
mutant resulted in significantly less bone loss compared to wild-type and the 
complemented strain. The virulence of the mutant was restored back to wild-type 
levels when the qseC mutation was complemented with a plasmid-borne copy of 
the qseC gene. Asterisk indicates statistical significance relative to sham; ~ relative 
to wild-type; D relative to the complemented strain. Values are mean ± SEM. N = 6. 
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(p = 0.0036) strains of A. actinomycetemcomitans exhibited significantly more alveolar 
bone resorption relative to sham-infected mice. However, animals infected with either the 
IsrB- or rbsB- mutant strains exhibited a significant reduction in bone resorption relative 
to wild-type (isrB-, p = 0.0285; rbsB-' p = 0.0134), suggesting that the detection of AI-2 
by either receptor contributes to virulence. Consistent with this, mice that were infected 
with the IsrB-rbsB- double-receptor mutant did not display significant levels of bone 
resorption compared to the sham-infected controls. As shown in Figure lOB, animals that 
were infected with the qseC mutant exhibited significantly lower bone resorption than 
wild-type (p < 0.02) and were indistinguishable from the sham infected controls. The 
virulence of the qseC mutant was restored to wild-type levels when it was genetically 
complemented with a plasmid-borne copy of qsec. These results suggest that both QseC 
and the ability to detect AI-2 contribute to the virulence of A. actinomycetemcomitans, 
and that a defective AI-2-dependent quorum sensing pathway negatively impacts the 
ability of A.actinomycetemcomitans to induce alveolar bone resorption. 
Inactivation of /uxS does not influence A. actinomycetemcomitans virulence: 
Previous studies showed that a luxS' mutant of A. actinomycetemcomitans formed 
biofilms that exhibited reduced total biomass and biofilm depth relative to wild-type 
biofilms (196). Since the luxS gene is responsible for the production of AI-2, and AI-2 is 
essential for the formation of biofilms, we next examined the importance of luxS in the in 
vivo virulence of A. actinomycetemcomitans. As shown in Figure IIA, the extent of bone 
resorption induced by A. actinomycetemcomitans luxS' mutant was indistinguishable from 
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Figure 11. The iuxS mutation is complemented in vivo. The iuxS- mutants of A. 
actinomycetemcomitans (A) and P. gingivalis (B) induced alveolar bone resorption at 
levels that were comparable to the wild-type or the iuxS complemented strain. 
Asterisk indicates statistical significant difference relative to sham. Values are mean 
± SEM. N=6. 
resorption over the sham-infected controls (wild-type p = 0.0052; iuxS- mutant p = 0.0365; 
iuxS complemented p = 0.007). Similar results were obtained when animals were infected 
with wild-type and iuxS- mutant strains of another periodontal pathogen, P. gingivalis 
(see Figure lIB). Thus, inactivation of the AI-2 receptors, but not the AI-2 synthase, 
affected A. actinomycetemcomitans virulence. This suggests that AI-2 produced by 




Dental plaque is a complex oral biofilm comprised of a diverse microbial 
community, consisting of more than 700 different bacterial species (1, 11 0, 116, 118, 
164,237) that must co-exist and adapt to the fluctuating environment of the oral cavity. It 
is likely that both intra- and interspecies communication occurs between these organisms, 
and that these processes may enable oral organisms to coordinate their behavior and 
function based on their local environment and the other organisms that occupy the same 
niche. For A. actinomycetemcomitans, this intimate cell-to-cell communication 
potentially occurs via the quorum sensing circuit dependent upon the soluble signaling 
molecule AI-2 (54). Indeed, previous studies showed that AI-2 regulates both biofilm 
formation and various iron acquisition pathways in A. actinomycetemcomitans (55, 196). 
However, it is not known how the initial detection of AI-2 is linked to downstream 
regulation of gene expression that controls these complex phenotypes. A. 
actinomycetemcomitans does not possess the dedicated two-component system that 
controls the cell-density-dependent response of Vibrio spp. to AI-2 (i.e. the LuxQ sensor 
kinase, LuxU phosphorelay protein, LuxO response regulator, or the LuxR master 
regulator of lux operon). Instead, the genome of A. actinomycetemcomitans encodes two 
periplasmic proteins, LsrB and RbsB, which function as receptors for AI-2, and each is 
linked to a putative ABC transporter that may import the signal (88, 195). Thus, the AI-2 
response circuit in A. actinomycetemcomitans may be similar to that described by Li et al. 
for E. coli, in which the LsrR regulator controls the expression of genes involved in 
biofilm growth as well as regulating the expression of the lsr operon when bound to AI-2 
that has been phosphorylated by the LsrK kinase (124). AI-2 has also been suggested to 
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regulate motility and biofilm formation in E. coli through the QseBC two-component 
system (62, 210). The A. actinomycetemcomitans genome also encodes the QseBC two-
component system, and our results here show that qseBC is a part of the AI-2 regulon in 
A. actinomycetemcomitans since qseBC is induced by the AI-2 signal itself, and its 
induction requires a functional AI-2 receptor. Furthermore, AI-2-dependent induction of 
QseBC in E. coli required the MqsR regulator (62). MqsR has been shown to be part of a 
toxin/anti-toxin system and adopts an alB fold similar to the RelE family of bacterial 
RNase toxins (24). Consistent with this, Yamaguchi et al. have also shown that MqsR 
functions as a GCU-specific mRNA interferase (244). MqsR is similar to open reading 
frame Aa00673 in the A. actinomycetemcomitans genome (www.oralgen.lanl.gov), which 
is co-expressed with Aa00672. Aa00673 and Aa00672 exhibit approximately 65% 
sequence identity to the HigBA toxin/anti-toxin system of Vibrio cholerae, which also 
functions as an mRNAse (30). This suggests that QseBC may participate in the AI-2 
response circuit in A. actinomycetemcomitans, and that Aa00673 may contribute to 
qseBC regulation (see Chapter 4). 
Consistent with QseBC functioning III the AI-2 quorum sensing pathway, 
inactivation of the QseC sensor influences the formation of biofilms by A. 
actinomycetemcomitans in that the qseC mutant forms biofilms that are reduced in total 
biomass, average biofilm depth, and maximum biofilm depth relative to biofilms formed 
by the wild-type strain. The biofilm growth phenotype of the qseC strain closely 
resembled the growth phenotype of the A. actinomycetemcomitans luxS mutant 
previously reported by Shao et al (196). Complementation of the qseC mutation restored 
biofilm formation, and indeed, the complemented strain formed biofilms that exhibited 
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greater average depth and biomass than wild-type. This may be due to the gene dosage of 
qseC in the complemented strain, since qseC was expressed from a multi-copy number 
plasmid in this organism. These data suggest that the QseC sensor, and presumably the 
QseB response regulator, may be part of the quorum sensing circuit mediated by AI-2 in 
A. actinomycetemcomitans. 
However, although the QseC sensor may be common to the AI-2 signal 
transduction pathway of both A. actinomycetemcomitans and E. coli, other aspects of 
these AI-2 response circuits appear to differ. Sperandio et al. have shown that E. coli 
0157:H7 QseC responds to stress hormones (epinephrine/norepinephrine and 
adrenaline/noradrenaline) as well as the microbial signal autoinducer-3 (AI-3), and that 
QseC may function in a one-to-many branched signal transduction pathway that activates 
the QseB, QseF and KdpE response regulators (82, 173). In addition, the QseE sensor 
kinase was shown to reside downstream of QseC in the adrenergic signal transduction 
cascade (82). At present, the signal that the A. actinomycetemcomitans QseC kinase is 
sensing is not known, and we have been unsuccessful in identifying AI-3 in A. 
actinomycetemcomitans extracts (D.R. Demuth, unpublished). Furthermore, paralogs of 
the QseE, QseF and KdpE polypeptides could not be identified in the A. 
actinomycetemcomitans genome at a search stringency that readily detected QseC using 
the E. coli QseC sequence as query. This suggests that the components that reside 
downstream from QseC in A. actinomycetemcomitans may differ from some E. coli 
strains. Interestingly, E. coli 0157:H7 lacks MqsR and transcription of qseBC is 
independent of AI-2 in this organism. 
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Biofilm growth in A. actinomycetemcomitans is dependent upon AI-2-mediated 
quorum sensing (196), and formation of biofilms is essential to the in vivo survival and 
virulence of dental pathogens in the oral cavity. Our results show that AI-2-mediated 
quorum sensing is important for A. actinomycetemcomitans virulence in vivo since 
mutants that were deficient in either of the AI-2 receptors (LsrB or RbsB) induced lower 
levels of alveolar bone resorption than the wild-type strain and a double-receptor mutant 
was essentially avirulent. These phenotypes are also consistent with the biofilm 
phenotypes exhibited by these mutant strains (196). The qseC mutant was also avirulent 
and did not induce bone loss over the sham-infected control group. This is consistent with 
QseC participating in and residing downstream from the AI-2 receptors in the AI-2 
response circuit as shown in the model presented in Figure 12. Nonetheless, the exact 
mechanism(s) through which QseBC contributes to the intracellular response of AI-2 as 
well as biofilm growth in A. actinomycetemcomitans IS not known. A. 
actinomycetemcomitans possesses the protein LsrR, which is the master regulator of the 
Isr operon in Samonella enteric (218, 219), and Gonzalez-Barrios et al. suggested that 
AI-2-dependent biofilm growth of E. coli requires internalization of AI-2 (62). In A. 
actinomycetemcomitans, the QseBC two-component system may couple the 
detection/importation of AI-2, either alone or in cooperation with LsrR, to downstream 
regulation of biofilm formation and other cellular processes. 
At present, the sets of genes that are regulated by the QseBC two-component 
system in A. actinomycetemcomitans are not known, but it is of interest that qseBC also 
exhibits sequence similarity to the feuPQ two -component system that regulates iron 
acquisition in several other bacterial species. Several operons that encode iron acquisition 
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pathways have been previously shown to be regulated by AI-2 (55), and iron availability 
is also known to dramatically il)fluence biofilm formation by A. actinomycetemcomitans 
(177, 178). Thus, it is possible that the biofilm defect that arises from inactivation of 
qseC occurs in part from the dysregulation of iron acquisition mechanisms. We 
demonstrated here that the QseC sensor regulates the acquisition of iron by A. 
actinomycetemcomitans. While both afuA 00696 andfecB 00795 were upregulated in the 
qseC mutant, not all iron-uptake genes showed differential expression in the qseC 
mutant. Our data indicates that the QseBC two-component system regulates the 
expression of some but not all iron-acquisition genes regulated by AI-2, suggesting that 
the QseBC regulon may include other components important for biofilm formation. 
Along these lines, QseBC was shown to regulate biofilm formation and motility in E. coli 
(62). Interestingly, A. actinomycetemcomitans is a non-motile organism, which also 
suggests the qseBC regulon mediates the expression of other genes important in biofilm 
formation. 
Since luxS was previously shown to influence biofilm growth (196), it was 
surprising that neither A. actinomycetemcomitans nor P. gingivalis luxS' mutants 
exhibited attenuated virulence in the murine model. A possible explanation for this result 
is that the luxS' mutation was complemented by AI-2 produced by organisms that are 
indigenous to the murine oral cavity. Consistent with this, McNab et al. have shown that 
AI-2 crosstalk occurs in dual species biofilms of Streptococcus gordonii and P. gingivalis 
(139). In this system, dual species biofilms formed efficiently even if one of the strains 
harbored a luxS mutation, but no biofilms formed if both strains were LuxS-deficient. Our 
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Figure 12. The AJ-2 quorum sensing circuit in A. actinomycetemcomitans. 
For A. actinomycetemcomitans, we hypothesize that AI-2-dependent biofilm 
formation and other potential AI-2-mediated cellular processes may result from 
one or two possible pathways. AI-2 is initially bound by its periplasmic receptors 
and imported into the cell by ABC-type transporters associated with the Isr and 
rbs operons. Once inside the cell, AI-2 is presumed to be phosphorylated by LsrK 
and phosphorylated AI-2 is thought to interact directly with LsrR, resulting in de-
repression of the Isr operon. However, LsrR may also interact with 
unphosphorylated AI-2 as suggested by Li et al. (124). Regulation of the QseBC 
two-component system may occur either through direct interaction with AI-2, or 
its expression may be induced by LsrR. The QseBC two-component system in 
turn alters the expression of genes that mediate biofilm formation, and potentially 
other genes, including those important for iron acquisition. 
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actinomycetemcomitans and P. gingivalis, and that the AI-2 signal of A. 
actinomycetemcomitans is capable of modulating the expression of luxS-regulated genes 
in P. gingivalis (54). In addition, Rickard et al. showed that the ability of the oral 
microbes Actinomyces naeslundii and Streptococcus oralis to form dual-species biofilms 
in saliva was dependent on AI-2 produced by S. oralis (180). The inability to detect or 
respond to AI-2 prevents the stimulation of the AI-2 response circuit and results in 
reduced biofilm growth and attenuated virulence, whereas the inability to produce AI-2 
was likely overcome by the presence exogenous signal produced by other bacteria in the 
murine oral cavity. 
Since luxS was previously shown to control biofilm growth (196), it was 
surprising that neither A. actinomycetemcomitans nor P. gingivalis luxS mutant exhibited 
attenuated virulence in the murine model. A possible explanation for this result is that the 
luxS mutation was complemented by AI-2 produced by organisms that are indigenous to 
the murine oral cavity. Consistent with this, McNab et al. have shown that AI-2 crosstalk 
occurs in dual species biofilms of Streptococcus gordonii and P. gingivalis (139). In this 
system, dual species biofilms formed efficiently even if one of the strains harbored a luxS 
mutation, but no biofilms formed if both strains were LuxS-deficient. Our previous 
studies also showed that AI-2-mediated crosstalk is possible between A. 
actinomycetemcomitans and P. gingivalis, and that the AI-2 signal of A. 
actinomycetemcomitans is capable of modulating the expression of luxS-regulated genes 
in P. gingivalis (54). I n addition, Rickard et al. showed that the ability of the oral 
microbes Actinomyces naeslundii and Streptococcus oralis to form dual-species biofilms 
in saliva was dependent on AI-2 produced by S. oralis (180). The inability to detect or 
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respond to AI-2 prevents the stimulation of the AI-2 response circuit and results in 
reduced biofilm growth and attenuated virulence, whereas the inability to produce AI-2 
was likely overcome by the presence exogenous signal produced by other bacteria in the 
murine oral cavity. 
In summary, we have shown that the QseBC two-component system is induced by 
AI-2, and that QseC is important for biofilm formation and virulence of A. 
actinomycetemcomitans. Our results suggest that QseC is part of the AI-2 response circuit 
and resides downstream of the AI-2 receptor proteins LsrB and RbsB. Further definition 
of the genes regulated by the QseBC two-component system may identify new targets for 
therapeutic intervention of aggressive periodontitis and other systemic infections 
associated with A. actinomycetemcomitans. 
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CHAPTER FOUR: CHARACTERIZATION OF A TOXIN-ANTITOXIN SYSTEM 
INVOLVED IN AI-2-DEPENDENT QUORUM SENSING IN 
AGGREGATIBACTER ACTINOMYCETEMCOMITANS 
Introduction 
Periodontal disease is a serious and widespread health ailment worldwide in the 
adult population. A hallmark of periodontal disease is that it is caused by a complex oral 
biofilm that is comprised of over 700 species of bacteria. Major shifts in the populations 
of certain microbes in the oral biofilm have been implemented in the progression of the 
disease, as diseased sites often have an increase of pathogens relative to residential 
microbes (131, 132, 134). However, the host and/or microbial shifts that contribute to 
these populational shifts are still unknown. The oral cavity is not a static environment and 
is constantly subjected to continual environmental fluxes, such as pH, temperature, 
nutrient supply, and osmolarity. Amazingly, though, oral bacteria are able to detect and 
properly respond to these changes, allowing them to successfully coexist and thrive in the 
oral cavity (2, 87, 134). Intra- and interspecies communication is one mechanism which 
enables bacteria to respond to their environment by coordinating their behavior and 
function and regulating gene expression as a community. One mechanism of 
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communication is quorum sensing, a cell-density dependent response, which is regulated 
by the production, release, and subsequent detection of signaling molecules called 
auto inducers in Gram-negative bacteria (116, 140, 190, 253). The external concentration 
of the auto inducer continues to increase as a population of bacteria expands until a 
threshold is reached, at which point a signal transduction pathway is initiated, changing 
gene expression and behavior of the microbial community. Therefore, it has been 
suggested that quorum sensing may enable bacteria to respond appropriately to changes 
in the environment, thereby reacting as a multi-cellular organism. 
A. actinomycetemcomitans, a known periodontal pathogen, IS associated with 
aggressive periodontitis as well as other systemic diseases (20, 159, 203, 250). Previous 
research has shown that A. actinomycetemcomitans possesses an AI-2-dependent quorum 
sensing circuit (54), and that AI-2 regulates virulence factors (54), biofilm formation 
(196), iron acquisition (54, 55), and in vivo virulence in a mouse model of A. 
actinomycetemcomitans infection (154). While the proteins that were related to the Vibrio 
AI-2 receptor were identified in A. actinomycetemcomitans, genes related to the 
dedicated two-component system (LuxQ sensor, LuxU phosphorelay, LuxO response 
regulator protein) have not been found in A. actinomycetemcomitans. Although the two-
component system encoded by QseBC is regulated by AI-2 and controls biofilm growth 
and virulence in A. actinomycetemcomitans (154), as shown in Chapter 3, exactly how 
the detection and/or internalization of the AI-2 signaling molecule leads to downstream 
gene regulation of complex phenotypes is not fully known. 
The QseBC two-component system is also known to regulate biofilm formation 
and motility in E. coli (62, 210). Previous studies have shown that in some strains of E. 
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coli expression of the QseBC two-component system is regulated by MqsR (62). MqsR 
might potentially be located upstream of QseBC in the AI-2 response circuit in E. coli, as 
deletion of the mqsR gene resulted in a 61-fold decrease in QseBC expression and 
decreased biofilm formation. It has been proposed that the signaling molecule AI-2 
stimulates expression of mqsR, which then induces expression (either directly or 
indirectly) of the QseBC two-component system. QseBC then influences gene expression 
leading to biofilm formation (62). Recently, MqsR was demonstrated to be the toxin of a 
toxin-antitoxin (TA system) encoded by MqsRA (24), and expression of this TA system 
is highly expressed in biofilms (62), and has been shown to be a GCU-specific mRNA 
interferase (244). 
The genomes of all free-living bacteria scrutinized thus far encode a number of 
toxin genes (96, 243), and it is thought that organisms have acquired these systems 
through horizontal gene transfer (228). Interestingly, the toxins produced by these genes 
are not intended to kill other bacteria or host cells, but instead are produced 
intracellularly and are toxic to their host cells, resulting in cell growth arrest and often 
cell death (50, 227, 228, 243). This process has been termed programmed cell death and 
has been suggested to be the prokaryotic equivalent of apoptosis (50). Many of these 
toxins are co-transcribed with their cognate antitoxins in an operon termed Toxin-
Antitoxin (T A) systems. The antitoxin and toxin form a stable complex in the cell, 
suppressing toxicity under normal growth conditions. However, the stability of the 
antitoxin is significantly lower compared to the toxin; thus any stress causing cellular 
damage or growth inhibition induces the expression of proteases that alter the equilibrium 
between toxin and antitoxin, resulting in release of the toxin into the cell (31, 96, 243). 
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The genome of A. actinomycetemcomitans was shown to possess a two-
component system that displays 70-80% sequence similarity to the QseBC two-
component system of E. coli. Furthermore, previous studies demonstrated that AI-2 
induces QseBC and a functional AI-2 receptor is needed for induction. In addition, 
inactivation of qseC resulted in a significant decrease in biofilm formation and in vivo 
virulence of A. actinomycetemcomitans, suggesting that QseBC is part of the AI-2 
regulon (154). Interestingly, A. actinomycetemcomitans also possesses open reading 
frames (ORFs) (Aa0672 and Aa00673) that have sequence similarity to the MqsRA TA 
system. Both Aa00672 and Aa00673 appear to be located in a pathogenicity island in the 
A. actinomycetemcomitans genome, suggesting that these genes may have been 
horizontally acquired by A. actinomycetemcomitans. In this study, we show that Aa00673 
is coexpressed in an operon with Aa00672. Aa00673 encodes a toxin which causes 
growth inhibition, and this growth inhibition is reversed by its cognate antitoxin, 
Aa00672. Furthermore, expression of Aa00673 is reduced in both the IsrB-rbsB- double 
AI-2-receptor mutant and the qseC mutant, suggesting that stimulation of toxin follows 
detection and internalization of AI-2 as well as the QseBC two-component system. 
Additionally, we show that Aa00673 may function as an RNase. Thus, Aa00672 and 
Aa00673 may regulate the expression of the QseBC two-component system, which in 
turn, influences downstream expression of genes in AI-2-dependent quorum sensing. 
Results 
ORF Aa00673 and ORF Aa00672 are expressed in an operon: 
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The QseBC two-component system has been shown to regulate AI-2-dependent 
phenotypes in both A. actinomycetemcomitans (154) and E. coli (62). Gonzalez Barrios et 
al further demonstrated that qseBC are regulated by mqsR in E. coli, and that mqsR might 
reside upstream of QseBC in the AI-2 signaling circuit (62). Interestingly, the genome of 
A. actinomycetemcomitans encodes several putative TA systems, including ORFs 
Aa00672 and Aa00673 (Figure 13a), which exhibit similarity to mqsRA. 
Since most toxins are co-transcribed with their cognate antitoxins in an operon 
(31, 96, 243), we wanted to determine if ORFs Aa00672 and Aa00673 were co-
transcribed together. Aa00672 is a 114-residue protein, and Aa00673 is an 84-residue 
protein. Reverse-transcription PCR was carried out using cDNA synthesized from total 
RNA extracted from A. actinomycetemcomitans strain 652. As shown in Figure 13b (lane 
2), when using 100 ng of cDNA and primers that span the region from Aa00672 to 
Aa00673 (5' and 3' TA transcript primers; see Table 2b), the expected 271-bp band was 
detected. This band was not detected in the reaction carried out without the addition of 
reverse transcriptase (Figure 13b, lane 4). This demonstrate that Aa00673 is co-
transcribed with the downstream gene Aa00672. 
Aa00673-Aa00672 expression is induced by components in the AI-2 regulon: 
Gonzalez Barrios et al has previously shown that MqsR is a component in the AI-
2 response circuit of E. coli. Deletion of mqsR in E. coli resulted in a significant in a 61-
fold decrease in the expression of qseBC, suggesting that MqsR regulates expression of 
the QseBC two-componet system in E. coli (62). To determine if AI-2 regulates ORF 
Aa00672 and ORF Aa00673 in A. actinomycetemcomitans, the expression of this putative 
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Figure 13. ORFs Aa00672 and Aa00673 are coexpressed. A) Operon structure of 
Aa00672 and Aa00673. Both genes appear to be located on a pathogenicity island, 
upstream of the cytolethal distending toxin genes. B) Total RNA was isolated from 
A. actinomycetemcomitans cells. RT-PCR reactions were performed, and the 
resulting eDNA was amplified in a PCR reaction with primers that span both 
Aa00672 and Aa00673 (size: 271 bp). Resulting PRC products were resolved on an 
agarose gel stained with ethidium bromide. Lane 1: 2-log ladder; Lane 2: 100 ng 652 
eDNA; Lane 3: 100 ng 652 genomic DNA; Lane 4: 100 ng No reverse transcriptase 
control; Lane 5: Negative control (water as template). 
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TA system was examined using real-time PCR with RNA isolated from overnight 
cultures of the qseC mutant and the lsrB-rbsS- mutant. As shown in Table 5, the 
expression of the Aa00672-Aa00673 was down-regulated 4.5-fold in the qseC mutant. In 
addition, induction of Aa00672-Aa00673 was not seen in the lsrB-rbsS- strain of A. 
actinomycetemcomitans, which lacks the AI-2 receptors, but which can still produce AI-
2. This suggests that the ORFs Aa00672 and Aa00673 are part of the AI-2 regulon in A. 
actinomycetemcomitans, and is located downstream of detection and internalization of 
signal as well as the QseBC two-component system. 
Table 6. ORFs Aa00672-Aa00673 are regulated by the AI-2 regulon. 
Strain delta Tl delta (delta T) Fold Change 
652 4.02 ± 0.15 0.062 ± 0.007 1.0 
qseC 6.21 ± 0.25 0.014 ± 0.002 0.22 ± 0.019 
lsrS-rbsS- 6.03 ± 0.41 0.016 ± 0.005 0.25 ± 0.047 
I delta T was calculated by subtracting the cycle threshold (Ct) determined for 
the 00696 reaction from the Ct of the 5S rRNA control. 
Aa00673 is a toxin and Aa00672 is its cognate antitoxin: 
T A systems are expressed in an operon together, such that under normal growth 
conditions a stable toxin-antitoxin complex is formed, suppressing the toxic activity of 
the toxin (31, 96, 243). Since ORFs Aa00672 and ORF Aa00672 in A. 
actinomycetemcomitans were previously shown to be regulated by components of the AI-
2 regulon and also co-transcribed together in an operon (see results above), we wanted to 
determine whether these ORFs actually encode a toxin and an antitoxin. The Aa00673 
gene alone or both ORF Aa00672 and ORF Aa00673 together were cloned into the 
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isopropyl ~-D-l-thiogalactopyranoside- (IPTG) -inducible pET30a plasmid and 
transformed into E. coli. Uninduced cultures of E. coli, which contain the pET30a-
Aa00673 construct but were not induced to express it, did not have a defect in cell 
growth; whereas inhibition of cell growth was visible 30 minutes after induction of 
Aa00673 in E. coli (Figure 14a). However, induction of the construct expressing both 
Aa00673 and Aa00672 together did not halt cell growth of E. coli (Figure 14b). This 
indicates that Aa00673 encodes a toxin, and Aa00672 encodes its cognate antitoxin, 
negating the toxic activity of Aa00673. 
Aa00673 causes reversible growth inhibition: 
Since Aa00673 causes growth inhibition when overexpressed in E. coli BL21 
cells, we wanted to determine if this inhibition was a bateriostatic or a bactericidal effect. 
This was achieved by inducing the cells as previously described, but then two hours after 
induction, IPTG was removed, the cells were resuspended in fresh LB medium, and the 
OD600nm readings of the E. coli cultures resumed every 30 minutes. As shown in Figure 
15a, removing IPTG from the induced cultures resulted in a growth rate similar to the 
uninduced cultures. However, the OD600nm of the induced cultures never reached the 
same level as the uninduced cultures. Furthermore, cell viability plating demonstrated 
that after removal of the inducer, the induced cells began proliferating again (Figure 15b). 
Similar to the grow rate, the CPU/ml never reached the same concentration as the 
uninduced cultures. This phenomenon may be due to the fact that the starting OD600nm of 
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Figure 14. ORF Aa00673 induces growth arrest that is negated by the 
expression of ORF Aa00672. Effect on bacterial growth measured as OD600nm. 
Bacteria were grown without IPTG (blue diamonds), and in the presence of 1 rnM 
IPTG (green squares). Growth was measured every 30 minutes after induction. 
Results are mean ± standard deviation. A) E. coli BL21 with the pET30a-AA00673 
construct was induced at an OD600nm of 0.4. Control cultures were not induced. B) 
E. coli BL21 with the pET30a-AA00673/ AA00672 construct was induced at 
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Figure 15. ORF Aa00673 induces reversible growth arrest. Effect on bacterial 
growth measured as OD600nm. Bacteria were grown without IPTG (blue 
diamonds), and in the presence of 1 mM IPTG (green squares). A) E. coli BL21 
with the pET30a-AA00673 construct was induced at an OD600nm of 0.4. Control 
cultures were not induced. Two hours after induction both induced and uninduced 
controls were washed 3x, and then resuspended in LB. Results are mean ± 
standard deviation. B) Appropriate dilutions were plated at certain time points 
throughout the growth curve. Plates were incubated overnight at 37C, colonies 
counted. and CFU/rnl calculated. 
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Figure 16. Effect of Aa00673 on RNA stability. RNA transcript marker was 
incubated with affinity-purified His-AA00673 for 15 minutes at 3rC in 10 mM 
Tris-HCl (pH 8.0) containing 1 mM dithiothreitol. The products were separated 
on a 1.2% agarose gel stained with ethidium bromide. Lane 1: 2ug RNA + Oug 
protein; Lane 2: 2ug RNA + 5ug protein; Lane 3: 2ug RNA + 10ug protein; Lane 
4: 2ug RNA + 20ug protein. 
more CFUs per ml in the uninduced cultures compared to the induced cultures. These 
results are consistent with the previous growth curve (Figure 14a), which showed that 
while induction of Aa00673 resulted in cell growth inhibition, the OD600nm values 
increased slightly over time, suggesting that some cells were able to continue to divide 
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over time. Taken together, these results imply that though Aa00673 inhibits cell growth, 
it is only a bateriostatic effect and easily reversible upon removal of the inducer. 
RNase activity of Aa00673: 
Yamaguchi et al recently demonstrated that MqsR functions as the toxin in the 
MqsRA TA system in E. coli (244), and ORF Aa00673 in A. actinomycetemcomitans has 
sequence similarity to MqsR. In addition, Aa00673 and Aa00672 also show sequence 
identity (approximately 65%) to the HigBA TA system of Vibrio cholera, and the toxin 
HigB is known to function as an mRNase (30). Thus, we wanted to see if Aa00673 also 
functions as an RNase. To determine whether the putative toxin AA00673 functions as an 
RNase, an RNA transcript marker (7 defined transcripts ranging from 0.1-1 kb) was 
incubated with increasing amounts of affinity-purified His-AA00673 in vitro. Figure 16 
shows dose-dependent degradation of the RNA marker as the concentration of purified 
AA00673 increases, suggesting that Aa00673 may indeed function as an RNase. 
Discussion 
The environment of the oral cavity is one of constant fluctuations in temperature, 
pH, osmolarity, and nutrients. In order to survive these conditions, bacteria must be able 
to appropriately detect, respond, and adapt to their surrounding environment (2, 87, 134). 
Bacteria express sophisticated mechanisms to sense and quickly react to the challenges 
presented by the oral cavity, and one of these mechanisms is termed quorum sensing. 
Quorum sensing is the ability of bacteria to regulate gene expression in response to 
soluble signaling molecules called autoinducers; thus, quorum sensing allows the 
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microbial community to coordinately sense the concentration of autoinducer and regulate 
their gene expression in response (116, 140, 190, 253). One type of quorum sensing 
circuit, which recognizes the autoinducer AI-2, is common in several Gram-negative and 
Gram-positive bacteria, and has been hypothesized to be a universal quorum sensing 
signal (14, 216,231,240). However, the AI-2-specific LuxPQUO-response circuit is not 
present outside of the Vibrionales, and as a result, it has been proposed that AI-2 may not 
playa role in quorum sensing in all organisms, but instead may function as a by-product 
of metabolism (43, 240). While this may be true for some bacteria, this is not consistent 
in those bacteria with phenotypes that are associated with the AI-2 quorum sensing 
pathway. Consequently, an alternative AI-2 signaling pathway may exist in organisms 
that lack the LuxPQUO signaling transduction circuit, such as A. 
actinomycetemcomitans. 
Our previous studies began elucidating a potential alternative AI-2-dependent 
quorum sensing circuit in A. actinomycetemcomitans involving the QseBC two-
component system. We demonstrated that AI-2 induces the QseBC two-component 
system, and that this two-component system influences cellular processes such as biofilm 
formation, iron-uptake systems, and in vivo virulence in A. actinomycetemcomitans (154). 
Studies by Gonzalez Barrios et al showed that expression of the QseBC two-component 
system and biofilm formation is induced by the protein MqsR (62). MqsR has been 
recently characterized as a toxin in a TA system, MqsRA (24). Additionally, MqsR is 
only present in those strains of E. coli where QseBC regulates biofilm formation in an 
AI-2-dependent manner (62). Interestingly, the genome of A. actinomycetemcomitans 
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encodes ORFs (Aa00672 and Aa00673) which share sequence similarity to MqsR of E. 
coli, suggesting these ORFs may be involved in AI-2-dependent quorum sensing. 
In this work, we demonstrate that the Aa00672 and Aa00673 are co-transcribed in 
an operon, an important characteristic of TA systems. Additionally, we show that 
expression of Aa00672 and Aa00673 is not induced in the qseC mutant or the IsrB-rbsS-
mutant, suggesting that this TA system is a component in the AI-2 signaling transduction 
cascade. In contrast to E. coli, where activation of MqsR influences the expression of 
qseBC (62), it appears that the TA system in A.actinomycetemcomitans resides 
downstream of the QseBC two-component system in the AI-2 regulon (Figure 17), where 
it is able to post-transcriptionally regulate downstream gene expression in the AI-2-
dependent quorum sensing circuit. 
We also show that ORF Aa00673 functions as a toxin, inhibiting cell growth, 
when expressed in E. coli. Consistent with this result, expression of the entire TA system 
(ORF Aa00672-Aa00673) did not result in inhibition of cell growth, indicating that 
Aa00672 is the cognate antitoxin of Aa00673, and negates its toxic effects on cells. The 
ability of the toxin to inhibit cell growth, however, is a reversible effect because after 
removal of IPTG, the growth rate of the induced cultures was similar to the growth rate 
of the uninduced cultures. It should also be noted that the culture of E. coli induced to 
express the toxin continued to slightly grow over time, which is also consistent with the 
toxin causing reversible cell growth inhibition. Indeed, the OD600nm of the induced 
cultures never reached the levels of the uninduced cultures, but this may be due to 
inefficient removal of the inducer. 
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Toxins that are mRNA interferases degrade mRNA with substrate specificity, and 
can be viewed as global regulators. Global regulators, such as Hfq and CsrA, regulate 
gene expression at the post-transcriptional level by differential mRNA decay (153). 
Yamaguchi et al has recently shown that MqsR functions as a GCU-specific mRNA 
interferase (244), and the MqsRA was the first TA system to be demonstrated as a global 
regulator. Deletion of mqsR either by replacement with kanamycin resistance cassette or 
by a transposon insertion resulted in enrichment of 76 transcripts in E. coli BW25113 and 
MG1655 (9, 62,101). However, these mutations had a polar effect on downstream mqsA, 
so transcriptome studies were also performed where MqsR production in BW25113 wild-
type strain was assessed, and it was found that MqsR production triggered a global 
change in the profile of the transcriptome with 132 transcripts enriched (101). The global 
change that was observed was due to the mRNA interferase activity of MqsR. Since ORF 
Aa00673 is a putative paralog of MqsR, we tested whether Aa00673 functions as an 
RNase. Our results in this study show that ORF Aa00673 may function as an RNase as 
well. Further analysis is needed to determine if Aa00673 specifically cleaves at GCU 
sequences as well as to determine additional genes Aa00673 may regulate. 
Hundreds of genes, including are known to be differentially regulated during 
biofilm formation, including stress-associated genes (17,44, 175, 191). Studies involving 
mutants of Streptococcus mutans which lacked homologues of the mazF and relE toxin 
genes did not appear to have an effect on biofilm formation as compared to the parental 
strain, implying that TA systems did not playa role in biofilm formation (119). However, 
recent studies have connected the MqsRA T A system to biofilm formation in E. coli. A 
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Figure 17. Current model of AI-2-dependent quorum sensing in A. 
actinomycetemcomitans. LuxS produces AI-2 and it is exported outside the cell. 
Once AI-2 is subsequently detected and internalized into the cell, one outcome is 
the induction of the QseBC two-component system, which may occur through the 
regulator LsrR. The QseBC two-component system has been shown to regulate a 
subset of AI-2-regulated iron-uptake genes, and potentially regulates other genes 
and operons that may influence quorum-sensing dependent behaviors, such as 
biofilm formation. The putative T A system (Aa00672-00673) is also downstream 
of the QseBC system. Thus, this model provides two pathways that can affect 
gene expression in A. actinomycetemcornitans: 1) transcriptionally via QseBC; 
and 2) post-transcriptionally via the putative TA system. 
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transcriptome study which identified differentially regulated genes in biofilms showed 
that the mqsR gene was induced in E. coli biofilms (175), and follow-up studies 
corroborated the importance of MqsRA in biofilm formation (62). Additionally, deletion 
of the RelEB TA system resulted in a 2-fold decrease in biofilm formation at 24 hours in 
both rich and minimal media (113). Since biofilm formation and quorum sensing are 
intimately connected in A. actinomycetemcomitans (196), and we have shown that ORFs 
Aa00672-Aa00673 are part of the AI-2 regulon, it is possible that biofilm formation is 
influenced by this putative TA system in A. actinomycetemcomitans. Studies are under 
way to determine the role ORFs Aa00672-Aa00673 play in biofilm formation in A. 
actinomycetemcomitans. 
A phenomenon closely linked to biofilm to formation is that of persister cell 
formation. Persister cells are a subpopulation of bacteria that are viable after treatment 
with lethal concentrations of antibiotics (123), but are not drug-resistant mutants because 
further culturing reverts them back to wild-type (200). Persister cells are typically found 
in biofilms and in stationary-phase cultures (123), and this phenotype contributes to the 
antibiotic-tolerance of biofilms (193). It is proposed that TA systems playa major role in 
persister cell formation, inducing a state of dormancy and allowing the cell to escape the 
effects of the antibiotics (89, 123). The MqsRA TA system in E. coli was the first to be 
linked to persister cell formation. Deletion of mqsR alone and the mqsRA locus resulted 
in a decrease in persister cell formation whereas production of MqsR/MqsA increased 
persistence (103). Additionally, mqsR was shown to be greatly induced in persister cells 
compared to nonpersister cells (193). Other toxin genes (e.g. relE, higB, mazF, yaJQ, and 
yoeB) have also been shown to be highly induced in persister cells (98, 107, 193). Thus, 
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since ORFs Aa00672-Aa00673 in A. actinomycetemcomitans have sequence similarity to 
the toxin MqsR and the HigBA TA system, both of which are known to be involved in 
persistence, this putative TA system may potentially be involved in persister cell 
formation in A. actinomycetemcomitans. This suggests that ORFs Aa00672-Aa00672 
may participate in AI-2-mediated biofilm formation by inducing persistence when the 
environment of the oral cavity becomes unfavorable (e.g. antibiotic treatment), allowing 
the cells to survive. 
Although we show here that ORFs Aa00672 and Aa00673 appear to function as a 
TA system in A. actinomycetemcomitans, this TA system differs from canonical TA 
systems in several ways. First, unlike other TA systems, the toxin precedes the antitoxin 
in the operon in A. actinomycetemcomitans. This has only been reported in three other 
T A systems: hicAB, higBA, and mqsRA. Furthermore, the higA gene has its own promoter 
located with the higB gene. Second, in previously characterized T A systems, the toxin is 
basic while the antitoxin is acidic. The opposite is true in this T A system-the toxin is 
acidic (pI 5.18) and the antitoxin is basic (pI 8.95). And third, the antitoxin (114 residues) 
is larger than the toxin (84 residues) in A. actinomycetemcomitans whereas the toxin in 
normally larger. Thus, it appears that Aa00672-Aa00673 in A. actinomycetemcomitans 
differs from the traditional TA system known in other bacteria. 
In summary, we have shown that ORFs Aa00672-Aa00673 in A. 
actinomycetemcomitans function as a TA system. Our results suggest that ORFs 
Aa00672-Aa00673 are part of the AI-regulon, residing downstream of the QseBC two-
component system. Further characterization of this T A system III A. 
actinomycetemcomitans may provide a better understanding of the AI-2-dependent 
91 
quorum sensing pathway as well as new targets for the treatment of periodontal disease 
and other systemic infections associated with A. actinomycetemcomitans. 
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CHAPTER FIVE: SUMMARY 
LuxS is widely disturbed throughout Gram-negative and Gram-positive bacteria 
(14, 189, 207, 240), suggesting that AI-2 functions as a universal quorum sensing signal 
that mediates intra- and interspecies communication (14, 215, 231, 240). Recent studies 
have proposed that AI-2 may not function as a quorum sensing signal in all bacteria, but 
instead may just playa metabolic role in the Activated Methyl Cycle (43, 240). Yet, there 
is also strong evidence that AI-2 behaves as a cell-to-cell communication signal, 
regulating cellular processes, such as biofilm formation, iron acquisition, and motility 
through cell-to-cell communication in species of bacteria that lack the conserved two-
component response in Vibrio spp (62, 196). Thus, AI-2 may function via alternative 
signaling cascades in organisms such as A. actinomycetemcomitans and E. coli, which 
lack the dedicated two-component system in the Vibrionales. 
The potential alternative AI-2 quorum sensing pathway that resides downstream 
from LsrR might be a mechanism through which species of bacteria, such as A. 
actinomycetemcomitans and E. coli, communicate without the presence of the dedicated 
two-component system in the Vibrionales. Gonzalez-Barrios et al demonstrated that Lsr-
dependent importation of AI-2 regulates motility and biofilm formation in E. coli as well 
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as QseBC, an AI-2-dependent two-component signal transduction system (62). The 
genome of A. actinomycetemcomitans encodes a two-component signal transduction 
system that displays 70-80% sequence similarity to QseBC of E. coli. While the sequence 
similarity of QseC extends across the entire gene, the sequence similarity of QseB is only 
conserved in the receiver domain of the response regulator. The sequence similarity of 
the DNA binding domain of QseB in A. actinomycetemcomitans deviates significantly 
from its E. coli counterpart, which suggests that a different set of genes is regulated by 
QseB in the dental pathogen (154). This is consistent with the fact that QseBC is known 
to regulate motility in E. coli (60), whereas A. actinomycetemcomitans is a non-motile 
organism. Furthermore, QseBC exhibits significant sequence similarity to the feuPQ two-
component system that regulates iron uptake in Rhizobium leguminosarum, 
Sino rhizobium meliloti, and Brucella suis (46). Iron acquisition dramatically influences 
biofilm formation in A. actinomycetemcomitans. We show here that AI-2 induces the 
QseBC two-component system in A. actinomycetemcomitans, and induction follows 
detection and internalization as a functional AI-2 receptor was needed. QseBC was also 
shown to regulate biofilm formation, iron acquisition, and in vivo virulence of A. 
actinomycetemcomitans. Thus, QseBC may couple the detection and/or importation of 
AI-2, either alone or in cooperation with LsrR, to downstream regulation of iron 
acquisition genes and biofilm formation in A. actinomycetemcomitans (150). 
Additionally, Gonzalez Barrios et al also demonstrated that MqsR regulates 
expression of QseBC and that mqsR might reside upstream of qseBC in the AI-2 
signaling cascade. Deletion of the mqsR gene in E. coli led to a 61-fold decrease in qseBC 
expression and to significantly decreased biofilm formation (62). Recently, MqsR was 
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demonstrated to be the toxin of a toxin/antitoxin system encoded by mqsRA (97, 102) 
This mqsRA toxin/antitoxin system is highly expressed in biofilms (60) and has been 
shown to function as a GCU-specific mRNA interferase (244). The genome of A. 
actinomycetemcomitans encodes several toxin/antitoxin systems, including open reading 
frames Aa00672 and Aa00673, which exhibit similarity to the toxin/antitoxin systems 
mqsRA and mazEF-both of which encode RNA interferases. Aa00672 and AA00673 
appear to reside in a pathogenicity island in the A. actinomycetemcomitans genome, 
suggesting that these genes may have been acquired by A. actinomycetemcomitans. Our 
results here show that Aa00672 and Aa00673 are co-expressed in an operon. We also 
show that Aa00673 is a toxin, causes reversible growth inhibitioin, and may function as 
an RNase; Aa00672 is its cognate antitoxin, negating the effects of the toxin. However 
unlike in E. coli, our studies show that induction of Aa00672-Aa00673 follows QseBC, 
indicating that QseBC controls Aa00672-Aa00673. Thus, Aa00672 and Aa00673 may 
influence the expression of QseBC, which, in turn regulates downstream expression of 
genes in AI-2-dependent quorum sensing. 
This dissertation describes the AI-2-dependent quorum sensing circuit 10 the 
dental pathogen A. actinomycetemcomitans. Recent studies described in this dissertation 
suggest that an alternative quorum sensing exists in A. actinomycetemcomitans and 
potentially other species of bacteria. This regulatory transduction circuit may connect the 
detection and internalization of AI-2 by the Lsr and/or Rbs transporters to downstream 
regulators, such as QseBC and MqsR, which influence cellular processes that contribute 
to virulence, iron uptake, and biofilm formation. As a result, these alternative AI-2 
quorum sensing pathways represent a viable target for novel therapeutic treatments to 
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control the populations of pathogens and biofilm formation. However, the prevalent 
distribution of LuxS and AI-2 among bacteria and the likelihood that AI-2 is needed for 
the establishment of commensal bacteria in the oral biofilm poses a challenge for 
developing new therapeutics which target AI-2 quorum sensing in bacteria. Previous 
studies have already reported the effects of differing AI-2 concentrations have on 
different organisms in the oral biofilm. For example, it has been shown that extremely 
low concentrations of AI-2 are needed for the association of some commensal organisms 
whereas Gram-negative oral pathogens produce much higher concentrations of AI-2 (58). 
As a consequence, developing therapeutic treatments which target the quorum sensing 
circuit of pathogens without affecting the commensal quorum sensing circuit might be a 
potential hurdle. Future studies are needed to provide a better understanding of how 
communication occurs among bacteria which lack the LuxPQUO signaling cascade found 
in the Vibrionales. This will help facilitate the development of specific quorum sensing 
inhibitors and may also reveal other cellular components important in the AI-2 quorum 
sensing circuit which may serve as viable targets for the treatment of biofilm-associated 
diseases. 
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CHAPTER SIX: FUTURE DIRECTIONS 
The role of the LsrR operon in AI-2-depedendent quorum sensing: 
In S. en te rica , the lsr operon is regulated by LsrR which binds to AI-2 that has 
been phosphorylated by LsrK (239). Furthermore in E. coli, LsrR has been shown to 
regulate other genes as well and may be involved in biofilm growth (62). In addition, 
LsrR may modulate AI-2 depedent regulation of QseBC. Similar to E. coli, the genome 
of A. actinomycetemcomitans possesses both the QseBC regulon as well as the LsrR 
operon. Previous research has shown that the periplasmic receptors, RbsB and LsrB, not 
only interact with AI-2 but are also essential for AI-2 dependent biofilm formation by A. 
actinomycetemcomitans (195). Both lsrB and rbsB are linked to operons-lsrACDBFG 
and rbsDABCK, respectively-that encode putative ABC type transporters and other 
gene products such as putative kinase and aldolase enzymes, which may modify or 
process AI-2 (88, 195). However, it is unknown whether the response circuit of AI-2 
requires these functions or if these functions constitute a pathway to recycle AI-2 after 
the cellular response has been initiated by LsrB and/or RbsB. In addition, preliminary 
studies have shown that inactivation of lsrK resulted in reduced biofilm growth in A. 
actinomycetemcomitans as compared to wild-type cells and that qseBC expression is 
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reduced in the IsrK mutant. Thus, it is important address the hypothesis that the LsrR 
operon connects AI-2 detection and importation to the expression of QseBC in A. 
actinomycetemcomitans. 
Global regulation of QseBC in A. actinomycetemcomitans: 
This dissertation shows that the expression of QseBC is induced by the quorum 
sensing signal AI-2 in A. actinomycetemcomitans and induction of QseBC requires the 
AI-2 receptors, LsrB and/or RbsB. While the sequence similarity of QseC extends across 
the entire gene, the sequence similarity of QseB is only conserved in the receiver domain 
of the response regulator. The sequence similarity of the DNA binding domain of QseB 
in A. actinomycetemcomitans deviates significantly from its E. coli counterpart, 
suggesting that a different set of genes are influenced by QseB in the dental pathogen. 
This is consistent with the fact that QseBC is known to regulate motility in E. coli, 
whereas A. actinomycetemcomitans is a non-motile organism. Thus, in order to better 
understand the qseBC regulon, transcriptome sequencing will be completed comparing 
the expression profile of wild-type strain 652, qseC mutant, and qseC complemented 
strain. Since this approach will most likely generate numerous differentially expressed 
genes, the results will be initially prioritized by concentrating on the differentially 
expressed genes that are apt to playa critical role in biofilm formation. The expression of 
these genes will be confirmed by real-time PCR. The function of the genes that are 
chosen for further study will be determined by generating isogenic knockout strains and 
analyzing biofilm formation as previously described. 
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The ygiW-qseBC operon in A. actinomycetemcomitans: 
Sperandio et al previously demonstrated that the QseC protein in E. coli 0157:H7 
responds to both epinephrine/norephinephrine as well as the microbial signal AI-3, and 
that QseC may function in a one-to-many-branched signal transduction circuit that 
activates the response regulators QseB, QseF, and KdpE (82, 173). Additionally, the 
QseE sensor kinase was shown to be located downstream of QseC in the adrenergic 
signal transduction cascade (82). Attempts to identify the AI-3 molecule in A. 
actinomycetemcomitans extracts have been unsuccessful. Additionally, paralogs of QseE, 
QseF, and KdpE polypeptides were not identified in the genome of A. 
actinomycetemcomitans. Presently, the signal that A. actinomycetemcomitans QseC 
kinase senses is not known. We show in this dissertation that qseBC are co-transcribed 
together in an operon. We also have preliminary data that this operon also contains 
another gene, ygiW, which is located upstream of qseB, and is also co-transcribed with 
qseBC. ygiW is annotated as a periplasmic solute-binding protein in the A. 
actinomycetemcomitanas genome, but it is unknown that this point how, or even if, ygi W 
intergrates into the QseBCIAI-2 signaling transduction pathway. It is possible that ygiW 
detects a signal (possibly host stress hormones) and relays the signal to QseC, integrating 
microbe and host signaling. Further studies are needed to understand the role ofygiW. 
The function of ORFs Aa00672-Aa00673 in A. actinomycetemcomitans: 
Thus far, the characterization of Aa00673 has been completed by cloning the gene 
into an expression vector and inducing its expression in E. coli. While this approach 
provided preliminary data about the function of Aa00673, it does not confirm its 
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functional role in A. actinomycetemcomitans. Consequently, it is critical that the function 
of ORFs Aa00672 and Aa00672 be studied in its native organism. In order to accomplish 
this, deletions of both of these genes will be constructed, deleting each gene alone and 
also deleting the entire putative TA system. The resulting mutants will then be analyzed 
in their ability to form biofilms, regulate iron uptake genes, and influence in vivo 
virulence. The expression of the QseBC two-component system will also be determined 
in these mutants in order to confirm previous results concerning the location of this 
putative TA system in the AI-2 regulon. Additionally, since MqsRA was shown to be a 
global regulator (62), it may be advantageous to also perform transcriptome sequencing 
on the Aa00672-Aa00673 mutant, comparing its transcripts to wild-type strain 652 and 
the Aa00672-Aa00673 complemented strain. These results will provide us with a greater 
understanding of genes that are regulated by this putative T A system and potentially 
involved in AI-2 regulon, highlighting other components that may serve as targets for 
therapeutic intervention of biofilm-associated diseases. 
Cellular stresses which induce ORFs Aa00672-Aa00673 in A. 
actinomycetemcomitans: 
Current hypotheses propose that T A systems are induced by cellular stress events, 
resulting in either programmed cell death (growth inhibition followed by cell death) or 
reversible cell growth inhibition (3, 32, 33, 165, 184, 185). However, the exact stresses 
that induce the activation putative T A system Aa00672-Aa00673 in A. 
actinomycetemcomitans are currently obscure. Thus, in order to elucidate the signals 
which activate this potential TA system, A. actinomycetemcomitans cells will be grown 
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under different stress conditions (e.g. iron-deplete environment, nutrient-limited 
environment, anaerobic environment, temperature stress, pH stress, antibiotic treatment, 
etc.), and the expression of Aa00672-Aa00673 will be analyzed by real-time PCR. This 
will provide preliminary evidence on the signals which activate this TA system. It may 
also be of interest to analyze the expression of this T A system in both a planktonic 
culture as well as a biofilm, especially since A. actinomycetemcomitans is present in the 
oral cavity in an adhered microbial community, and it is possible that this putative TA 
system may be induced in a biofilm setting. Additionally, the genome of A. 
actinomycetemcomitans encodes several other identified putative T A systems. Thus, it 
may also be advantageous to determine the signals that also activate these systems. 
The function of other T A systems in A. actinomycetemcomitans: 
Prokaryotes appear to encode several T A systems in their genome. While not all 
TA systems act in the same manner, it is possible that each putative TA system allows the 
cell to respond to specific stresses, allowing for the achievement of one major, redundant 
function: cell survival. For example, MqsR, MazF, YafQ, and ChpB cleave mRNA at the 
GCU (244), ACA (252), AAA (171), and ACY (Y = A or G) (59) sites, respectively. 
However, MazF degrades most mRNAs under antibiotic stress, but the mRNAs which are 
not degraded are utilized to produce a pool of specific proteins-some are used for 
toxicity while some are used for cell survival (5). Similarly, MqsR specifically cleaves 
mRNAs and enriches the mRNA pool for those that encode for DNA replication inhibitor 
CspD as well as other stress proteins (e. g. RpoS, ClpP, ClpB, and CstA) that help the cell 
cope with the stress and survive (179). Thus, it seems that under cellular stress, the role 
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of each T A system may be to not only reduce growth by a specific mechanism, but also 
to promote the survival of a population of cells. 
Although there have been multiple putative T A systems identified III A. 
actinomycetemcomitans, the role of only one-Aa00672-Aa00673-has been 
investigated and potentially linked to AI-2-dependent quorum sensing. It would be 
interesting to understand how other T A systems function, whether they are involved in 
quorum sensing, and if each works towards the same common goal of promoting cell 
survival. Additionally, it would be interesting to show if any of these putative TA 
systems signal through each other, forming a network ofTA system signaling. 
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